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Formulation of a High-Volume Small Molecule Drug Product 
Abstract 
Small molecule drug products play an enormous role in innovative treatments for a vast number of 
diseases and have comprised most annual FDA drug approvals each year to date. Thus, economically 
efficient mass production of small molecule drugs is an essential public health concern. While batch 
production of these types of pharmaceuticals dominates the industry, continuous manufacturing has 
emerged as a promising technology with positive economic implications. However, due to the newness of 
the technology, pharmaceutical companies have been reluctant to adopt continuous manufacturing. This 
project presents a full economic evaluation of batch versus continuous manufacturing of a high-volume 
small molecule drug product through ground-up design of production facilities and a target cost of 
conversion of one cent per tablet. The production of tablets from API (active pharmaceutical ingredient) 
is broken down into six different unit-operations—granulation, drying, milling, blending, compression, and 
coating. The batch and continuous processes are designed at the unit-operation level to determine 
equipment and utility costs, allowing for a rigorous profitability analysis. It was determined that the 
continuous manufacturing process is more profitable than the batch process. For a cost of conversion of 
one cent per tablet and a 21-year plant life, the batch process had an internal rate of return (IRR) of -0.3% 
and return on investment (ROI) of -2.4%, while the continuous process had an IRR of 8.4% and ROI of 
2.7%. Further analysis showed that increasing the cost of conversion to two cents per tablet resulted in an 
IRR of 26% and ROI of 17% for the batch process and an IRR of 37% and an ROI of 28% for the continuous 
process. Increasing the cost of conversion confirms that the continuous process is more profitable than 
the batch process. 
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Letter of Transmittal 
University of Pennsylvania, School of Engineering and Applied Science 
Department of Chemical and Biomolecular Engineering 
220 South 33rd Street 
Philadelphia, PA 19104 
 
April 20, 2021 
 
Dear Dr. Warren Seider, Professor Bruce Vrana, and Dr. Alex Marchut, 
 
 The following report contains designs for batch and continuous processes and 
manufacturing facilities for both processes to manufacture a small molecule drug product known 
as Clairatenol. Anticipated sales are 1 billion tablets per year, and the target cost of conversion is 
$0.01. Both processes include six unit-operations—granulation, drying, milling, blending, 
compression, and coating.  
  
 Economic analyses were completed for both processes. The batch manufacturing plant 
had a return on investment of -2.4%, and an internal rate of return of -0.3%. The continuous 
plant, on the other hand, had a return on investment of 2.7% and an internal rate of return of 
8.4%. These results show the potential of using continuous manufacturing as a more efficient and 
profitable alternative to batch manufacturing for producing small molecule drug products. 
Increasing the product price from $0.01 to $0.02 and $0.03 confirms our results, as the 
continuous process is consistently more profitable than the batch process. Consequently, we 
recommend that the continuous process is chosen, as it is the wiser investment. 
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Section 1: Abstract 
 
Small molecule drug products play an enormous role in innovative treatments for a vast 
number of diseases and have comprised most annual FDA drug approvals each year to date. 
Thus, economically efficient mass production of small molecule drugs is an essential public 
health concern. While batch production of these types of pharmaceuticals dominates the industry, 
continuous manufacturing has emerged as a promising technology with positive economic 
implications. However, due to the newness of the technology, pharmaceutical companies have 
been reluctant to adopt continuous manufacturing. This project presents a full economic 
evaluation of batch versus continuous manufacturing of a high-volume small molecule drug 
product through ground-up design of production facilities and a target cost of conversion of one 
cent per tablet. The production of tablets from API (active pharmaceutical ingredient) is broken 
down into six different unit-operations—granulation, drying, milling, blending, compression, and 
coating. The batch and continuous processes are designed at the unit-operation level to determine 
equipment and utility costs, allowing for a rigorous profitability analysis. It was determined that 
the continuous manufacturing process is more profitable than the batch process. For a cost of 
conversion of one cent per tablet and a 21-year plant life, the batch process had an internal rate 
of return (IRR) of -0.3% and return on investment (ROI) of -2.4%, while the continuous process 
had an IRR of 8.4% and ROI of 2.7%. Further analysis showed that increasing the cost of 
conversion to two cents per tablet resulted in an IRR of 26% and ROI of 17% for the batch 
process and an IRR of 37% and an ROI of 28% for the continuous process. Increasing the cost of 
conversion confirms that the continuous process is more profitable than the batch process. 
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Section 2: Introduction and Objective Time Chart 
Section 2.1 Project Background 
Small molecule drug products are defined as any organic compounds with low molecular 
weight that are manufactured through chemical synthesis and include most patented medicines 
on the market [61]. Small molecule drug products can be formulated as oral solid dosage forms, 
and this includes tablets and capsules that are efficient and cost-effective to manufacture and 
easy to administer [29]. Active Pharmaceutical Ingredients (APIs) are pharmaceutically active 
bulk drugs that induce a desired pharmacological effect and are formulated into small molecule 
drug products such as tablets and capsules. These small molecule drug products also contain 
excipients, which are inactive substances usually used as a carrier of the API in the drug. The 
functionality of excipients includes providing bulkiness to formulations, facilitating absorption 
of the drug, and providing stability and preventing denaturation of drugs [47]. There are many 
different types of excipients—binders, disintegrants, lubricants, colorants, and glidants [19]. 
Binders, such as microcrystalline cellulose, provide mechanical strength and form to the tablet as 
they hold together the API and excipients in the tablet [24]. Disintegrants accelerate the 
breakdown of the tablet in the body, and subsequently improve the oral bioavailability— the 
fraction of drug dosage that reaches the therapeutic site of action in the body—of the drug in the 
body [58]. Lubricants, such as magnesium stearate, prevent the tablets from adhering to the 
tablet press during compression. Colorants are used to make the drugs more recognizable for 
patients. Lastly, glidants help in improving powder flow by reducing friction and adhesion 
between particles [24]. 
Small molecule APIs can be formulated through two manufacturing processes—batch 
and continuous. During a batch process, there is a pause between each step as a batch moves 
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through. Continuous manufacturing is an uninterrupted, nonstop process from the start until the 
product is completed. Batch manufacturing is more common in the pharmaceutical industry and 
thus considered to be more reliable. However, continuous manufacturing has become more 
popular in the pharmaceutical industry due to advantages inherent to continuous manufacturing 
for high volume products. Continuous manufacturing is faster than batch manufacturing. 
Additionally, continuous manufacturing can be safer as it eliminates steps involving human 
intervention and significantly reduces the risk of error. Furthermore, continuous manufacturing 
can be cheaper after initial investment. According to the National Science and Technology 
Council, drug makers who implement continuous manufacturing could save between 40 and 50 
percent in variable costs compared to batch manufacturing [35]. The purpose of this project is to 
determine which design process would be more profitable and determine if the pharmaceutical 
industry would benefit from adopting continuous process design more frequently. 
 
Section 2.2 Project Goals 
This report focuses on determining whether a batch or a continuous manufacturing 
facility would be more economical for formulating a small molecule drug product. For this 
project, our goal is to design both batch and continuous processes to formulate a blockbuster 
drug product called Clairatenol and design manufacturing facilities for producing this drug by 
both processes. To design our manufacturing facilities, we have anticipated sales of 1 billion 
tablets per year, with a goal cost of conversion into tablets of 1 cent per tablet.   
            The chemical make-up of Clairatenol is classified, and the specific formulation of this 
drug cannot be discussed in this report. As a result, this drug is treated as a generic drug and the 
process is designed to be universal so that it can be used to produce different types of drugs. For 
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the analysis, a drug with the following make-up is used as a model—50% AP1, 26% excipients 
added during first blending, 2% binding, 18% excipients added during second blending and 4% 
coating. 
 
Section 2.3 Production Goals 
Both plants will be operating for 330 days per year for 24 hours. For the evaluation, a 
model drug of 325mg API with 50% drug load (650 mg/tablet) will be used to design both 
processes. However, both processes are designed to have the ability to produce drugs of varying 
shape, weight, dosage, and coating composition. To achieve the goal of producing 1 billion 
tablets per year with the model drug, the production facility needs to produce 650,000 kg/yr. For 
the batch process, the design facility needs to produce one 1970 kg batch per day to meet the 
production target. 2000 kg per batch per day is taken as the batch size for simplicity in 
calculations. The resulting mass of tablets produced per year for a 2000 kg batch per day is 
660,000 kg/yr. It should be noted that for all subsequent calculations for the batch process, the 
output per year is taken as 660,000 kg/yr. For the continuous process, the design facility needs to 
have a throughput of 82 kg/hr. 
 
Section 2.4 Design Process 
 
For this report, we will be evaluating which process is more profitable using economic 
analyses. Both processes include the following unit operations—blending, granulation, drying, 
milling, compression, and coating. 
Blending is a unit operation that occurs twice in the process design. First, there is an 
initial blending that occurs before granulation. Blending occurs once more after milling and 
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before compression. During blending, the API and excipients are blended to obtain a 
homogenized product with three mechanisms of mixing—diffusion, convection, and shear. A bin 
blender is used for the batch design, and a continuous blender is used for the continuous design. 
The next unit operation is granulation, which is followed by drying. During granulation, 
the particles are enlarged as powder particles are agglomerated while retaining the integrity of 
the original particles [52]. The powder formulation is a combination of the API and excipients. 
The excipients are important as they influence specific physical (size and flowability) and 
mechanical (hardness or deformability) behaviors. During this operation, fine powders are 
transformed into free-flowing dust particles that can be more easily compressed. For this design, 
a top-spray fluid bed granulator is used for the batch process in a vessel that incorporates both 
granulation and drying. For the continuous design, a twin-screw granulator and a continuous 
fluid bed dryer are used. 
Milling is the unit operation that occurs after granulation and drying. During milling, 
large clumps of the material are deagglomerated to achieve a more uniform particle size 
distribution. Milling contributes to improving drug dissolution and solubility [31]. This is a semi-
continuous process, so the same type of mill can be used for both designs. For both designs, a 
Quadro FlexSift S20 will be used as it screens for impurities and successfully breaks down 
particle clumps before the second blending operation.  
During compression, which occurs after the second blending step, a blend of powders 
containing pharmaceutical excipients and API are compressed into tablets. Tablet presses operate 
as a continuous process. Both batch and continuous process will utilize a continuous tablet press 
called a rotary tablet press.  
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The final unit operation for our design is tablet coating. The application of a coating gives 
the tablets the required appearance. There are different types of tablet coating solutions used to 
enhance specific functionality such as concealing bitter taste, creating smooth coverings to 
facilitate swallowing, protect the pill from damage due to external forces, and for branding. For 
our process designs, we use a fully perforated pan for the batch design and a shallower fully 
perforated pan for the continuous process. 
 
Section 2.5 Project Deliverables 
 
For this report, economic comparison of the two processes is the main deliverable and 
will be used to determine which process—batch or continuous—is a wiser investment. A 
complete profitability analysis was performed for both processes to determine which design 
process is more profitable. In Section 21, the economic analysis is discussed in detail. 
Throughout the development of the design of both manufacturing processes, assumptions were 
made that will be detailed throughout the report. 
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Section 2.6 Project Time Chart 
  
Week 1 Week 2 Week 3 Week 4 
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Complete 
preliminary research 
February Material Balances Energy Balances 
 




in SuperPro Designer 
March Selection of specific 
equipment for each unit 
operation  
Completion of 









































Section 4: Market and Competitive Analyses 
 
It is well established that the global pharmaceutical manufacturing market is one of the 
largest and most rapidly growing in the world, with its epicenter located in the United States. In 
2020, the pharmaceutical manufacturing market was valued at $405.52 billion USD and 
projected to grow at a compound annual growth rate of 13.7% [45].  The catalysts for growth in 
this market include consistent rises in R&D spending, advancements in technology, the rising 
focus on healthcare needs, growth of the geriatric population, the incidence rate of chronic 
disorders, increasing rate of FDA approvals, and generous healthcare legislation. In response to 
increasing demand for pharmaceuticals, manufacturers have been racing to explore more 
efficient means of production. This has led to an increased interest in continuous pharmaceutical 
manufacturing.  
 Pharmaceutical drugs can be split into two categories—biologics and small molecule 
drugs. While the market for biologics is growing rapidly, continuous manufacture of these types 
of pharmaceuticals is not yet possible and therefore will not be further discussed in this report. 
While greater emphasis has recently been placed on biologics, small molecule drugs still account 
for 90% of global drug sales [61]. Since 2015, four key players in the market—Vertex, Janssen, 
Eli Lilly & Co., and Pfizer—have adopted continuous manufacturing for at least one small 










Table 4.1: FDA Approved Drugs Manufactured Continuously as of 2021 
Approval Date Company  Product Treatment 
July 2015 Vertex Orkambi Cystic Fibrosis 
April 2016 Janssen Prezista  HIV 
September 2017 Eli Lilly & Co. Verezino Breast Cancer 
February 2018 Vertex Symdeko Cystic Fibrosis 
November 2018 Pfizer Daurismo Acute myeloid leukemia 
 
While the majority of small molecule drugs are produced using batch manufacturing, the 
adoption of continuous manufacturing by large companies reflects growing interest in the 
process and potential for greater future incorporation. However, this transition from a well-
established process to a new one requires great investment due to new start-up costs and costs 
associated with the difficulty of paving the way for a newer technology, including longer 
approval times and definition of new regulations. It has been observed that the majority of 
companies who have adopted this continuous form of pharmaceutical manufacturing have been 
motivated by future payoffs and a desire for innovation, rather than practical economic realities 
[52]. Additionally, Vertex has fallen under scrutiny for its pricing of Orkambi by the public, 
which is likely higher as a result of increased costs due to the start-up of a new continuous 
manufacturing facility [23]. While it may be difficult to motivate a company currently producing 
a small molecule product to switch from batch to continuous modes of production, the target 
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market for such technologies lies in scenarios where a company is looking to begin production of 
a new drug and is willing to invest in a brand-new facility.  
Despite initial economic deterrents, there is great support from the FDA and the 
pharmaceutical community to invest in continuous manufacturing as well as many projected 
economic and societal benefits. Janet Woodcock, Acting Commissioner of the FDA, has publicly 
announced an eagerness to partner with industry and academia to explore options in continuous 
manufacturing, and has emphasized that there are no regulatory hurdles though there may be a 
lack of experience [64]. A regularly cited benefit of continuous manufacture is its decreased 
dependence on the human operator. This may not only reduce operating costs, but also reduce 
human error and losses incurred because of it. Accordingly, this automation may increase the 
quality of products, which is essential in the world of pharmaceutical manufacturing, where most 
losses and production setbacks are the results of failed quality checks. It has also been 
hypothesized that continuous manufacturing can reduce capital costs, as smaller equipment is 
needed for the same production targets, and also reduce equipment idle time (associated with 
batch processes). While it has been proven that continuous manufacturing can be implemented to 
produce high-quality small molecule drugs, the hypothesis that it also reduces capital and 
operating costs have not been proven. This report seeks to compare the cost of designing a new 
manufacturing facility from the ground up for both a batch and continuous manufacturing 
facility, such that pharmaceutical companies deciding which route to pursue for the production of 
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Section 10: Preliminary Process Synthesis 
Section 10.1 Granulation 
 Granulation is the process of particle enlargement in which powder particles are 
agglomerated while retaining the integrity of the original particles. It transforms fine powders 
into free-flowing dust-free granules which are easily compressed [53]. Granules are produced to 
enhance the uniformity of the API in the final product, to increase the density of the blend so that 
it occupies less volume per unit weight, to facilitate metering or volumetric dispensing, to reduce 
dust production, and to improve the appearance of the product [53]. 
There are several options for batch granulation. The two major categories of granulation 
are wet and dry granulation. Wet granulation involves the addition of a liquid binder solution for 
granulation, while dry granulation does not. Wet granulation is preferred so long as the API is 
not largely heat or moisture sensitive [32]. Most generic small molecule tablets are produced 
using wet granulation, and it is assumed that the API is not heat or moisture sensitive, so wet 
granulation was chosen for this process. Within the category of wet granulation, there are several 
more options—fluid bed spray granulation and integrated high shear granulation. The main 
difference between the two types is the properties of the granules produced. It is found that high-
shear granules are denser, while fluid bed granules have a higher porosity and less spherical 
shape. It has also been reported that fluid bed granulators have a narrower particle size 
distribution [37]. It was decided that fluid bed granulation would be an appropriate choice for the 
granulation of a typical, small molecule drug product.  
There are several types of fluid bed granulators available for pharmaceutical applications, 
including top spray, tangential spray, and bottom spray fluid granulators. Top-spray fluid bed 
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granulation is the most well-established in the pharmaceutical industry and was chosen for this 
process [26]. 
 To lower capital costs, a single vessel capable of performing both fluid bed drying, and 
fluid bed granulation was chosen. Glatt is one of the industrial leaders in the production of fluid 
bed granulators and dryers, and the fluid bed granulator and dryer used in the batch process was 
modeled after their GPCG PRO 30 Fluid Bed Dryer Granulator. Cost estimates were obtained 
from a Glatt representative, and the brochure for this piece of the equipment is included in the 
appendix (Section 25.10.1).  
 Continuous pharmaceutical production is a relatively new field, and thus there are less 
options for continuous granulation equipment. The most widely cited equipment type used for 
continuous granulation in the literature is a continuous twin-screw granulator [27]. The twin-
screw granulator used in this process was modeled after the Thermo-Fisher Scientific Pharma 25 
Twin Screw Extruder. This model was found to be compatible with the selected continuous 
fluid-bed dryer, and capable of handling the required throughput for the system. A brochure for 
this piece of equipment is included in the appendix (Section 25.10.3).  
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Section 10.2 Drying 
 Fluid bed dryers are the most suitable for drying of granular crystalline, coarse, or similar 
material in pharmaceuticals, fine chemicals, dyes, food and allied products [44]. They are widely 
used across the pharmaceutical industry for the drying of wet granules, and therefore this type of 
dryer is used for both the batch and continuous processes. Fluid bed dryers are designed to 
introduce a hot air stream through the base of the vessel to fluidize its contents. The particles 
each get fully surrounded by hot air, resulting in efficient heat transfer. The only other 
reasonable option for the drying of pharmaceutical granules is a tray dryer, however fluid bed 
dryers occupy less floor space and can dry the material in less time [44]. 
 The granulator described in Section 10.1 for the batch process functions as fluid bed 
dryer as well as a fluid bed granulator, and an additional piece of equipment is not needed. The 
continuous fluid bed dryer used in this process is modeled after the one used in the MODCOS 
Figure 10.1.1: Glatt GPCG Pro Fluid Bed Granulator and 
Dryer vessel (B) and schematic showing trop-spray wet 
granulation technique. [58] 
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continuous production line manufactured by Glatt, and equipment brochures are included in the 
appendix (Section 25.10.2). The vessel is essentially a smaller model of the GPCG fluid bed 
dryer used in the batch process, but runs in continuous mode, and is compatible with the 




Section 10.3 Milling 
Milling is a semi-continuous process that improves drug dissolution and solubility [31] 
by making the particle size distribution more uniform. It also increases the surface area of the 
particles by breaking down particle agglomerates that may have formed after granulation and 
drying.  
Figure 10.2.1: Lab scale model of Glatt MODCOS continuous 
production line. This line incorporates the Glatt continuous fluid 
bed dryer and Thermo-Fisher Scientific Pharma 25 Twin Screw 
Extruder 
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The primary purpose for milling in this process is delumping and particle 
deagglomeration. The mill must be run at the least possible aggressive conditions to reduce fines 
generation. Fines are extremely fine particles produced when the mill is run at aggressive 
conditions. Accumulation of these particles is dangerous for the operator and can cause dust 
explosions. The Quadro FlexSift S20 was selected for both the batch and continuous 
manufacturing processes as it can gently delump the particles without particle size reduction and 
with very low fines generation. This equipment also improves security screening, as it can 
remove any impurities present in the material. 
The Quadro FlexSift S20 is also flexible. If milling at more aggressive conditions is 
required, the FlexSift S20 head shown in Figure 10.3.1 can be replaced with a Comil U20 head, 
which improves particle size distribution and causes particle size reduction. Further details about 
the equipment can be found in Section 15.1.3. Other equipment, such as the Hanningfield Uni-
Mill and Kek belt drive cone mill, was considered but ultimately rejected because it did not 
provide flexibility to change milling conditions depending on material properties and was more 
expensive than the FlexSift S20. A brochure for the Quadro FlexSift S20 is included in the 






Section 10.4 Blending 
Blending is the mixing of API and excipients to obtain a homogenized product. A 
uniform blend of API and excipients must be produced, and segregation of the mixture post 
blending must be prevented. Segregation is the separation of particles in the blend due to 
differences in properties such as particle size and density. It is dangerous because it can cause 
tablets from the same batch to have different API and excipient compositions, which can alter the 
tablets’ safety and efficacy [2]. The risk for segregation is low in these manufacturing processes 
as the output from the blender goes directly to the tablet press, without extra handling steps, and 
because the blend has been optimized by an R&D team such that the particles have just enough 
cohesivity to prevent segregation but are also sufficiently free flowing such that there are no 
interruptions to the process. Therefore, blending consists of producing an adequate blend, 
maintaining the blend through subsequent handling steps, and verifying that the blend is properly 
Figure 10.3.1: Quadro FlexSift S20 with motor and control panel 
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homogenized [2]. Blending validation will be optimized by the blending R&D team and is out of 
scope for this report. 
There are three mechanisms by which blending occurs—diffusion, convection, and shear. 
Diffusion is the random motion of particles, leading to the particles being redistributed. 
Convection is the movement of large groups of adjacent particles within the blend in the 
direction of flow. Shear helps in breaking particle agglomerates by facilitating the movement of 
one layer of material over another when both layers have different velocities. The degree to 
which these mechanisms contribute to producing a homogenized blend depends on the type of 
blender used and on flow properties [2]. 
For the batch process, based on a recommendation from our project author, the bin 
blender was selected. Other types of blenders include ribbon blenders and double-cone blenders, 
to name a few. The bin blender was chosen because it houses the blending bin and the drive 
mechanism separately, which increases the efficiency of the equipment because the bin can be 
charged, discharged, and cleaned separately. The bin containing the API and excipients rotates 
with the help of the drive mechanism to homogenize the mixture. LB Bohle was selected as the 
equipment manufacturer due to its stellar reputation in the pharmaceutical industry. Some 
headspace is needed in the bin blender to allow for the expansion of the material due to the 
motion of the blender. To accommodate the large batch size of 2000 kg with a bulk density of 
0.5 kg/L, an LB Bohle container blender (PM-6000) as shown in Figure 10.4.1 with a volume of 
6000 L and fill level of 20% to 85% was selected. Other vendors selling container blenders, such 
as GEA, were considered but the equipment sold by these vendors was unable to accommodate 
the large volume required for the batch. The value of fill level used in calculations in Section 
14.1.4 was 85%. Special containment flaps can be added to the blending container for dust-free 
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operations. A brochure for the LB Bohle container blender (PM-6000) is included in the 
appendix (Section 25.10.6).  
For the continuous process, based on the recommendation of our project author, the 
continuous blender was selected. Most continuous blenders are tubular in design with a shaft 
fitted axially in the center of the blender. The shaft has blades all over its surface for mixing the 
material and helping it move through the blender. Gericke was selected as the equipment 
manufacturer due to its stellar reputation in the pharmaceutical industry. The Gericke continuous 
blender (GCM-450) in Figure 10.4.2 was used for the process as it supported the required 
throughput for the process. An alternative under consideration was the Amixon continuous mixer 
(AMK-3000), but it was rejected because of its large size and large space requirements. 
Additionally, the power requirement of 22-30 kW for the AMK-3000 was much larger than that 
for the GCM-450 (0.37 kW). Therefore, the GCM-450 was chosen due to its modular design and 
lower power requirements. A brochure for the Gericke continuous blender (GCM-450) is 








Figure 10.4.1: LB Bohle PM-6000 container blender with 
discharge vessel to collect output 
Figure 10.4.2: Gericke continuous blender (GCM-450) 
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Section 10.5 Compression  
During compression, the blend of powder is run through a tablet press to be compressed 
into tablets. The tablet press is usually the point of the process where problems are first 
recognized as mechanical changes to raw material properties can result in variations from batch 
to batch [28]. There are two types of tablet presses—single punch and rotary tablet presses. The 
single punch is the simplest machine for tablet manufacturing. The rotary press is the more 
suitable machine for the scale of manufacturing being studied in this project. One of the benefits 
of the rotary tablet press is that it has high productivity with minimal labor. A rotary tablet press 
can achieve the output that is required for both the batch and continuous process. Additionally, 
the powder filled cavity can be managed automatically by the moving feeder. With the rotary 
tablet press, waste of valuable formulation can be decreased, and the machine allows 
independent control of weight and hardness of the tablets [46]. 
GEA’s MODUL P tablet press can be used for both designs and has been selected for its 
associated benefits. This tablet press is designed based on the exchangeable compression module 
[22]. All the product contact parts are contained in an isolated dust-tight module that can be 
removed in a contained manner, leaving the machine powder free. This machine has fast product 
changeover, improves productivity, provides a safe working environment and allows for 





Section 10.6 Coating 
There are three types of tablet coaters—standard coating pan, perforated pan, and 
fluidized bed/air suspension system. The standard coating pan is a circular metal pan that rotates 
with an electric motor. A perforated pan is a partial or fully perforated drum that rotates on a 
horizontal axis and is enclosed in sealing housing. A fluidized bed/air suspension system has a 
chamber that is usually a vertical cylinder where fluidization of the pellets is achieved by a 
column of air flowing upwards from the bottom center of the cylinder. The tablets in the center 
Figure 10.5.1: GEA’s MODUL™ P Tablet 
Press  
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move upwards in the air flow and fall outwards and downwards to the chamber wall, re-entering 
the air stream from the bottom part of the column. Spray nozzles located at the bottom and the 
top of the chamber are used to introduce the coating solution. A fully perforated pan is used for 
both the batch and continuous process because they show increasingly versatile coating 
capability, and they are reported to be more efficient than other methods in drying the tablet bed 
[30].  
There are several different perforated pans that could be used for the processes. 
Ultimately, it was decided that tablet coaters from Thomas Engineering would be used for both 
processes because the vendors provided the most information compared to the other vendors who 
were contacted. Additionally, Thomas Engineering is a leader in the in the tablet coating 
industry.  
For the batch process, Accela-Cota® tablet coating systems from Thomas Engineering 
are used. This machine features a fully perforated coating drum the revolutionized the coating 
manufacturing process when it was introduced in 1969. This machine continues to set standards 
for tablet coating with unrestricted air flow, thermodynamic efficiency, and flexibility [55]. 
Some additional benefits of this machine include reduced installation space, a highly accurate 
flowmeter for solution flow control, coating chamber geometry that is optimized for effective 
cleaning and drainage and a range of wash-in-place (WIP) options [55]. Figure 10.6.1 shows 
Thomas Engineering’s Accela-Cota® tablet coating system. A brochure for this equipment is 
included in the appendix (Section 25.10.8).  
For the continuous process, the Thomas Flex CTC® Continuous Tablet Coater from 
Thomas Engineering is used. This machine extends the film coating technology from the typical 
batch process to a fast and efficient continuous process. The Flex CTC® achieves the same high 
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performance demonstrated in the batch coaters but in much less time. Additionally, this machine 
offers the industry’s leading product volume and a complete system automation with the 
industry-leading Thomas Compu-Coat® control software that provides total process control, 
repeatability, and validation documentation [16]. Figure 10.6.2 shows Thomas Engineering’s 
Flex CTC® Continuous Tablet Coater. A brochure for this equipment is included in the appendix 
(Section 25.10.10).  
 
 





















Section 11: Assembly of Database 
 
The processes studied in this report involve solids handling, and do not involve any 
chemical reactions. Properties of the API involved in this process were not defined, and therefore 
the API and excipients were modeled to have the thermophysical properties (heat capacity, 
density, etc.) of water. Small molecule drug composition was modeled after that of 
acetaminophen. Each tablet was modeled to have 325 mg of active ingredient and a 50% drug 
load, resulting in a total drug weight of 650 mg. To meet the production goal of one billion 
tablets per year, this requires that 1970 kg of tablets be produced daily. The batch size was 
rounded to 2,000 kg to simplify calculations. The bulk density of the API and excipients was 
taken to be 0.5 g/mL. 
While several different types of excipients are used in the formulation of a small 
molecule drug product, differentiation of the type and therefore thermophysical properties of 
each type are beyond the scope of this project. Thus, each type is simply referred to as 
“excipient” and modeled with the properties of water. Different amounts of excipients enter the 
process at different times through various unit operations. All the API and 52% of excipients (by 
weight) enter the process during initial blending, 4% of excipients enter as part of the binder 
solution, 36% are added during the second blending step, and the final 8% enters as coating. This 
breakdown is represented in Table 11.1. The price of all the excipients is taken to be $0.05/kg.  
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Table 11.1. Excipient Addition Schedule 
 Percent API Added Percent Excipient Added 
Initial Blending  100 52 
Granulation 0 4 
Drying 0 0 
Milling 0 0 
Second Blending 0 36 
Compression 0 0 




















Section 12: Process 




Section 12: Process Flow Diagrams and Material Balances 
 
 Block flow and process flow diagrams for both the batch and continuous processes are 
presented in Figures 12.1.1-12.2.2. The block flow diagrams show a broad overview of each 
process and emphasizes the important flow rates or batch sizes, while the process flow diagrams 
show greater detail and includes smaller-scale process machinery and heat exchangers. Tables 
12.1 (batch) and 12.2 (continuous) provide detailed property descriptions of the streams reflected 
in Figures 12.1.2 and 12.2.2. Granulation and drying occur in the same vessel for the batch 
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Section 13: Process Descriptions 
 Both processes were designed using the same unit operations. However, the equipment 
and process specifications differ for each and are described in detail below.  
Section 13.1 Batch Process 
The batch manufacturing process is designed in such a way that solids flow is handled in 
a gravity driven manner, using split butterfly valves. Figure 12.1.1 shows the block flow diagram 
for this process, where the material flows through all the unit operations in six different vessels. 
Initial weighing, dispensing, and blending will occur on the top (fourth) floor of the building and 
will last for two hours. Next, the solids drop into the granulation and drying vessel on the third 
floor, where the materials are granulated for three hours and dried for six. After drying, the 
material flows to the mill on the second floor, where it will be milled for four hours. After 
milling, a second blending operation lasting two hours occurs on floor one before the material 
flows down to the ground floor for compression and coating. Compression is the bottleneck 
operation, and lasts approximately 21 hours, after which the material is transferred in mini bags 
using a forklift to the coater on the same floor. After six hours in the tablet coater, the process is 
complete. The detailed schedule for this process can be seen in Figures 13.1.1 and 13.1.2, 
representing the equipment occupancy and Gantt charts, respectively. It takes approximately 30 
minutes to load and unload each vessel, and this time is accounted for in the schedule. The 
equipment is cleaned using clean-in-place (CIP) followed by steam-in-place (SIP) operations 
after every eight batches, and the timing of these cleaning operations is shown in the Gantt chart. 
The total recipe batch time is about 47 hours, but the cycle time is only 24 hours, allowing for 







Figure 13.1.1. Equipment occupancy chart for two full batches. Process batch time is 46.5 hours, 
while the cycle time is 24 hours. The equipment is cleaned prior to use after every eight batches 
using CIP followed by SIP. 
Figure 13.1.2. Gantt chart for the batch process, showing the details of each unit operation. 
Times for cleaning, loading, and unloading equipment are all accounted for. 
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13.1.1 Top-Spray Fluid Bed Granulation 
 Granulation is the process of particle size enlargement through the agglomeration of 
powder particles. Granulation transforms the size, shape, and density of powders to improve their 
physicochemical properties and handling. This process transforms fine powders into free-flowing 
dust-free granules which are easily compressed further down the line. It also enhances uniformity 






There are several methods through which granulation can be performed, and they fall into 
two main categories: dry and wet granulation. During dry granulation, powder particles are 
agglomerated under high pressure, whereas during wet granulation, dry powders are 
agglomerated through implementation of a granulating fluid. The granulating fluid is made up of 
binders, or excipients that function to hold the granules together, and a volatile solvent, usually 
water. Binder choice depends on the properties of the API and desired granule qualities, but they 
usually come in the form of natural or synthetic polymers. Pregelatinized starch is used widely 
throughout the pharmaceutical industry and is therefore chosen as a model binder for this process 
[10]. For the batch process, fluid bed granulation will be implemented for this unit operation as it 
is well established in the pharmaceutical industry and can be performed in the same vessel as 
Figure 13.1.3. Granulation of powder changes the size, shape, and density of 




drying, resulting in lower capital costs. This vessel is represented by GR-1(B)/DR-1(B) in Figure 
12.1.2. The process begins with charging of the solids in stream S-3(B) into the vessel, followed 
by bed fluidization with hot air. Before reaching the vessel, the air is passed through a blower, 
BL-1(B), and a heat exchanger, HX-1(B), to heat it to the desired temperature. After the granules 
have been fluidized, the binder solution is pumped into the vessel through PM-1(B) from the top 
to achieve top-spray wet granulation. The details of this equipment can be found in section 
15.1.1. Granulation is run for three hours. There are several important design specifications 
associated with this process. Important process variables include fluidizing air flow rate, 
fluidizing air temperature, fluidizing air humidity, and liquid to solid (L/S) ratio. The L/S ratio is 
defined as the ratio of liquid binder solution flow rate to solid blend flow rate. There have been 
many experiments conducted to optimize these variables, and values were chosen based on 
comparison to similar processes reported in the literature, as well as heat transfer and humidity 
calculations, which are included in Section 25.3.1 [17]. Fluidizing air will be introduced to the 
system through stream S-11(B) at a volumetric flow rate of 2,800 m3/h at 55°C, and an absolute 
humidity of 10 (g water/kg air). Binder solution is added at a 20% w/w water to solids ratio, 
resulting in the addition of 344 kg of an 11% binder solution. Granulation will be performed 
under saturated conditions, and exhaust air will leave the vessel at a temperature of 25ºC and a 
saturated absolute humidity of 19.4 g water/kg air, resulting in evaporation of 62 kg of water 
during this process. The remaining 242 kg of water is evaporated during drying. After three 
hours, granulation is finished, and drying begins in the same vessel. The properties of the air 
streams associated with granulation are tabulated below. While there is a pressure increase 
through the blower, it is small enough to assume that the air physical properties are not affected.  
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Table 13.1.1. Properties of Air Stream for Fluid Bed Granulation 









S-9(B) 25 1.0 2,500 10.0 
S-10(B) 25 1.2 2,500 10.0 
S-11(B) (vessel inlet) 55 1.2 2,800 10.0 
S-14(B) (exhaust) 25 1.0 2,500 19.4 
 
13.1.2 Fluid Bed Drying 
After granulation, the wet granules must be fully dried. This will be accomplished 
through fluid bed drying, which has been extensively used in the pharmaceutical industry. The 
same blower described in Section 13.1.1, BL-1(B), increases the velocity of the air before it is 
sent to the heat exchanger, HX-1(B), through stream S-10(B), where it is brought to the desired 
temperature. The hot air is introduced through the bottom of the vessel in stream S-11(B) at a 
high enough velocity to fluidize the wet particles. The wet solids are suspended in the stream, 
and heat transfer occurs through direct contact of the hot air and wet solids, evaporating all the 
water and leaving behind the binder. The inlet air flow rate, temperature, and humidity were 
chosen to meet a desired drying time of six hours, and to agree with optimization variables found 
in the literature [54]. The heat transfer equations used to determine these parameters are detailed 
further in sections 14.1.2 and 25.3.2. An inlet air flow rate of 5,200 m3/h at 75°C was determined 
on the assumption of 80% heat transfer efficiency. The air enters at an absolute humidity of 10 g 
water/kg air and exits at 40°C and an absolute humidity of 21.4 g water/kg air, which is below 
the saturation point at this temperature. During drying, the granules are brought to an operation 
temperature of 40°C. Before the granules leave the system, the heat exchanger is turned off and 
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ambient air is run through the system long enough for the granules to cool back down to 25°C 
before they are transferred to the mill. Properties of the air streams involved in this process are 
tabulated in Table 13.1.2. 
Table 13.1.2. Properties of Air Stream for Fluid Bed Drying 









S-9(B) 25 1.0 4,400 10.0 
S-10(B) 25 1.2 5,200 10.0 
S-11(B) (vessel inlet) 75 1.2 4,400 10.0 
S-14(B) (exhaust) 40 1.0 4,600 18.7 
 
13.1.3 Milling 
After granulation and drying, particle agglomerates may have been formed, and these 
need to be broken down. The output from the granulator is introduced to the milling chamber 
with a screen around it. The rotation of the milling chamber forces the particles to go through the 
screen due to centrifugal acceleration [2]. The particles discharged from the screen are collected 
and are transported to the blender. Any impurities in the input material are left behind in the 
milling chamber. The milling for this manufacturing process primarily serves the purpose of 
delumping particle agglomerates, and so the generation of fines due to milling is negligible.  
Some process parameters for milling include the mill speed and screen size [2]. The mill 
is run at the least aggressive conditions possible, and so the mill speed is chosen to be 700 RPM 
to reduce the generation of fines. The screen consists of round holes with a diameter of 1.9 mm. 
These process parameters can be optimized by a process R&D team to further reduce the 
generation of fines. 
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For this process, the Quadro FlexSift S20 (Figure 13.1.4) as selected, as discussed in 
Section 10.3. Further details on the equipment are provided in Section 15.1.3. 
 
 
Figure 13.1.4. Schematic of Quadro FlexSift S20 
 
13.1.4 Bin Blender 
 Blending occurs twice in the batch process—once before granulation, and once after 
milling. The blending step before granulation is known as pre-blending, and it is necessary for 
achieving a uniform distribution of API and excipients in the powder mixture [53] prior to 
granulation. 1,000 kg of API and 520 kg of excipients are added to the pre-blender. As seen in 
Figure 12.1.1, excipients are added in both pre-blending and blending unit operations. 52% of the 
excipients are added during pre-blending, and 36% are added during blending. Most excipients, 
except lubricants, can be added during either pre-blending or blending. Lubricants are added 
during blending (after milling) as they facilitate tablet compression by preventing the tablets 
from adhering to the tablet punches in the tablet press. 
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 Some process parameters for blending include the loading order of materials into the 
blender, blender rotation speed, and fill level [2]. The amount of excipients added to the blender 
is low as compared to the other input to the blender from the mill. Thus, if all excipients are 
added first, then the blend may not be properly homogenized because the excipients could lie in 
one part of the blender and not spread into the mixture. Therefore, the input to the blender from 
the mill (mill output) and the input excipients can be added in two ways. Either the excipients are 
all added after the material from the mill is sitting in the blender, or both inputs are added in 
layers—first, a layer of the mill output, then a layer of excipients, followed by another layer of 
the mill output, and so on. Using either of these methods to load the blender ensures that the API 
and excipients are mixed uniformly [5]. As for blender rotation speed, as the amount of material 
to be blended increases, the required rotation speed decreases [8]. Lastly, the fill level of the 
blender is important as some headspace is required to accommodate the expansion of the 
material due to motion of the blender. A fill level of 65-75% is typical for bin blenders [2]. As 
mentioned in Section 10.4, the LB Bohle container blender (PM-6000) can have a working 
volume of 20-85%. Therefore, to accommodate the large batch size in a reasonably sized blender 
for the batch process under consideration, a fill level of 85% is used in calculations in Section 
14.1.4. 
For the batch manufacturing process, a bin blender is used. A bin blender (Figure 13.1.5) 
consists of a blending container that is rotated with the help of a drive mechanism. The rotation 
of the blender causes the particles to move by convection and diffusion. Bin blenders are low 
shear blenders as the blending mechanism is gentle and the shear forces are low. There are some 
shear forces due to slip plane formation between the walls of the blender and layers in the blend, 
but these shear forces are small as compared to those due to other types of blenders [2]. Bin 
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blenders are used for this batch manufacturing process as blending in this case is primarily 
needed for lubricating the formulation. An advantage of bin blenders is that the blending bin is 
separate from the drive mechanism, which increases the efficiency of the equipment because the 
bin can be charged, discharged, and cleaned separately. Therefore, bin blenders help in reducing 
the time needed for cleaning. More information about the bin blender is in Section 15.1.4.  
 
 
Figure 13.1.5 Schematic showing how a bin blender works. 
 
13.1.5 Rotary Tablet Press 
The feeder feeds the powder blend of API and excipients from the blender into the dies of 
the rotary press. In the rotary tablet press, there are several tooling stations that rotate to 
compress the powder blend into tablets. Figure 13.1.6 shows how the rotary tablet press operates. 
The compaction force is exerted on the fill cam by both the upper and lower punches, 
compressing the powder blend in the middle-accordion of the tablet press. The rotary tablet press 
capacity is determined by the rotation speed of the turret and the number of stations the tablet 
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press has. The pre-compression roller gives the granules the initial compression force and gets 
rid of excess air that is trapped in the die. The main compression roller applies the final 
compression force that formulates the tablets. The ejection cam guides the lower punch upwards 
and ejects the tablets from the die cavity [46]. The tablets are then discharged from the tablet 
press. The tablet press parameters are compression force (pre-compression force and main 
compression force), turret speed, and feeder speed [39]. Compression is the bottleneck operation 
for both processes. For the batch process, the tablet press runs for 21 hours to produce the 
required output of 144,300 tablets/hr. 
 
 Figure 13.1.6. Schematic of how a rotary tablet press works. In this process, the powder 
blend will be placed in the dies and compressed using the pre-compression roll and main 







13.1.6 Batch Fully Perforated Pan 
During coating, specific functionalities of the tablet are enhanced. These functionalities 
include concealing of any bitter tastes, creation of smooth coverings to facilitate swallowing, 
protection of the pill from damage due to external forces, and branding. There are different types 
of tablet coating solutions. Sugar coating obscures bitter taste and is mainly used for drugs for 
children. Film coated tablets are stable and strong and are used for tablet branding. Gelatin 
coated tablets are protein rich. Enteric coated tablets help to deliver the tablet to intestines 
without causing damage to the consumer. Other types of coating include electrostatic coating, 
dip coating, and rotary die coating. Since this is a generic design, this report does not specify the 
type of coating that the tablet has and assumes that tablet has some film coating [11]. For the 
analysis, the coating solution is assumed to contain mostly water and some carbohydrates. 
A fully perforated pan will be used for the batch process. The fully perforated pan rotates 
on its horizontal axis and the whole system is enclosed in sealed housing. The tablets are placed 
in the tablet bed and are sprayed with coating solution using a spraying arm as shown in Figure 
13.1.7. The drying air is passed through the tablet bed and is released through the perforations in 
the drum. The fully perforated pan shows increasingly versatile coating capability and is more 
efficient than other methods of drying [30]. The uncoated tablets are placed in the fully 
perforated pan and a coating solution is pumped into the fully perforated pan using the spraying 
arm as shown in Figure 13.1.7. The coating solution (790 kg/batch) is made up of a solution of 
90% water and 10% organic coating. For this process, the process airflow for drying the coating 
on the tablet was determined to be 17,900 m3/h and this air is heated to 75°C by the heat 
exchanger before entering the tablet coater to dry the coating. Properties of the air stream 
entering this process can be found in Table 13.1.3. The calculations for how the air flow was 
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determined can be found in Sections 25.3.1 and 25.3.2. This coating process will take 6 hours 
including drying. The evaporated water from the coating solution and the drying air is removed 
from the perforated pan through the exhaust. Before the tablets are removed from the system, the 
heat exchanger is turned off and ambient air is run through the system long enough for the tablets 
to cool down to 25°C from 45°C. 
Table 13.1.3. Properties of Air Stream Entering the Batch Coater 









S-16(B) 25 1.0 15,300 10.0 
S-17(B) 25 1.2 15,300 10.0 
S-18(B) (vessel inlet) 75 1.2 17,900 10.0 















Figure 13.1.7. Schematic of Fully Perforated drum 
for a batch process. In this process, the tablets are 
coated in the tablet with a coating solution using a 
spraying arm and dried with air as the perforated 
pan is rotates [57]. 
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Section 13.2 Continuous Process 
The continuous manufacturing process is designed in such a way that solids flow is 
handled in a horizontal manner, in a single floor facility. Figure 12.2.1 shows the block flow 
diagram for this process, where the material flows through all the unit operations in seven 
different vessels. Initial weighing, dispensing, and blending is the first step of the continuous 
process. Next, the solids are conveyed to the granulator, followed by the drying vessel. After 
drying, the material is conveyed into the mill. After milling, a second blending operation occurs, 
before the material is conveyed into the tablet press and coater. After each unit operation, the 
material is transferred to the next unit operation by using different types of conveying. The solid 
materials in the process are conveyed pneumatically through a piping system throughout the 
process until after the second blending (after milling). Screw conveying will be used to transfer 
the blend to the tablet press from the second blending operation to prevent segregation of the 
blend. Information about cleaning during the continuous process can be found in Section 20.4.  
13.2.1 Continuous Twin Screw Granulation 
 While the chosen method is different, the same principles described in Section 13.1.1 
apply for continuous granulation. For this process, a continuous twin-screw wet granulator 
(TSWG) will be used. Increased interest in continuous manufacturing has turned manufacturers 
in the pharmaceutical industry towards alternative methods for granulation, and twin-screw 
granulation (TSG) has emerged as the most prevalent continuous option [3]. As opposed to top-
spray fluid bed granulation, which is used for the batch process, twin screw granulation reduces 
labor and space, and can be operated at ambient temperatures. A schematic of this process is 
shown in Figure 13.2.1 and corresponds to vessel GR-1(C) of Figure 12.2.2. Twin screw 
granulators are comprised of mixing zones and kneading zones. After initial blending, powder is 
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conveyed to the TSWG and introduced through a feeder. It is first brought to the mixing zone, 
where the powder is mixed at room temperature with a binder solution. The kneading zone 
consists of two co-rotating screws composed of screw elements of desired geometry enclosed in 
a barrel. Parameters for this process include screw speed, liquid to solid (L/S) ratio, screw 
configuration, and barrel temperature. The L/S ratio is defined as the ratio of liquid binder 
solution flow rate to solid blend flow rate. Because this process focuses on the design of a 
versatile process, specifications of screw speed and geometry are ignored as they can be varied 
using the designed equipment without affecting economic and safety evaluation. Through 
analysis of figure 12.2.2, powder is introduced to the continuous granulator at a throughput of 62 
kg/h through stream S-3(C), and 10 kg/h of a 17% binder solution is pumped into the granulator 
through stream S-11(C) by PM-1(C) and added to the powder resulting in a 13% L/S ratio. The 
process is run at room temperature to eliminate any extra costs of heating, and the wet granules 











 Figure 13.2.1. Schematic of a twin-screw wet granulator. Powder is 
introduced after initial blending and conveyed first through the mixing zone 
where the binder liquid is introduced and then through the kneading zone 
where agglomerates are formed [49]. 
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13.2.2 Continuous Fluid Bed Drying 
 Continuous fluid bed drying follows the same principles as the fluid bed dryer described 
in section 13.1.2, however it is designed as a horizontal vessel where the wet granules are dried 
as they continuously flow through the vessel, as is shown in figure 13.2.2. Differing from the 
schematic in Figure 13.2.2, the wet granules are conveyed into the vessel from the TSWG and 
fluidized using hot air flow up through the bottom of the vessel. Heat transfer calculations were 
used to determine inlet air flow rate, temperature, and humidity, as described in section 13.1.2. 
Following the process flow diagram in Figure 12.2.2, the blower, BL-1(C) increases the velocity 
of the air in stream S-12(C) before it is sent to the heat exchanger, HX-1(C), in stream S-13(C), 
and heated to a temperature of 75°C. The air enters the dryer through S-14(C) at a volumetric 
flow rate of 1150 m3/h at an absolute humidity of 10 g water/kg air to achieve evaporation of 8 
kg/h of water, resulting in total drying. The air enters at an absolute humidity of 12.5 g water/kg 
air and exits at 40°C at 17.0 g water/kg air. The dry granules are heated to 40°C during the 
process but exit at 25°C after HX-1(C) is turned off and the granules are cooled using ambient 
air. Properties of the air streams involved in this process are tabulated below.  
 
 
Table 13.2.1. Properties of Air Stream for Continuous Bed Drying 









S-12(C) 25 1.0 1,040 10.0 
S-13(C) 25 1.1 1,040 10.0 
S-14(C) (vessel inlet) 75 1.1 1,150 10.0 













The same mill is used for the continuous manufacturing process. The output from the 
dryer is pneumatically conveyed to the mill. It should be noted that the drive motor value for the 
mill used for the continuous process was lower than that for the batch process due to lower 
throughput in the continuous process. The mill throughput for the continuous process was 64 
kg/hr.  
13.2.4 Continuous Blender 
Like the batch process, blending occurs twice in the continuous process—once before 
granulation, and once after milling. The blending step before granulation is known as pre-
blending, and it is necessary for achieving a uniform distribution of API and excipients in the 
powder mixture prior to granulation [53]. As seen in Figure 12.2.1, excipients are added in both 
pre-blending and blending unit operations. 52% of the excipients are added during pre-blending, 
and 36% are added during blending. Most excipients, except lubricants, can be added during 
Figure 13.2.2. Schematic of the continuous fluid bed dryer. In our process, 
material will be conveyed directly from the TSWG into the fluid bed dryer, 
where it flows horizontally and is fluidized by the inlet hot air, and dried using 
the heat input due to the air [21]. 
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either pre-blending or blending. Lubricants are added during blending (after milling) as they 
facilitate tablet compression by preventing the tablets from adhering to the tablet punches in the 
tablet press. 
The output from the mill is pneumatically conveyed and fed to the continuous blender at 
64 kg/hr. Excipients are fed continuously at 15 kg/hr to both the blender and pre-blender using 
loss-in-weight feeders. API is introduced into the pre-blender at 41 kg/hr using a loss-in-weight 
feeder. Continuous blenders (Figure 13.2.3) are cylindrical in shape with inputs being fed at one 
end and outputs leaving at the other end. These blenders contain a motor-driven shaft fitted 
axially in the center of the blender with many blades present along the shaft [38]. The rotation of 
the shaft and blades mixes the inputs added to the blender and facilitates the motion of the 
material through the blender. Using a continuous blender reduces the risk of segregation after 
blending because the particles are blended continuously, and the blend will be transported to the 
tablet press by a flexible screw conveyor. Also, continuous blenders are more compact, occupy 
less space, and can be scaled up easily to obtain higher throughputs. The Gericke GCM-450 
continuous blender was selected for this process. Further details on the equipment are provided 




Figure 13.2.3. Schematic of a continuous blender. 
 
13.2.5 Rotary Tablet Press 
The same tablet press is used for the batch and continuous process. Section 13.1.5 
describes how the tablet press operates. For the continuous process, the tablet press would 
operate for 24 hours to produce 126,300 tablets/hr.  
 
13.2.6 Continuous Fully Perforated Pan 
For the continuous process, a fully perforated pan is used as in the batch process, but with 
a shallow bed-depth that allows very high coating uniformity since the tablets are frequently 
exposed to the spray cone. The continuous tablet coater operates with the same principles as the 
batch tablet coater (Section 13.1.6). The tablets are fed into the tablet coater using a feeder at a 
rate of 79 kg/h, where they are exposed to the coating solution with multiple spray nozzles as 
shown in Figure 13.2.4. The coating solution is fed at a rate of 33 kg/h, and the solution is made 
up of 90% water and 10% organic coating. An air supply of 6,800 m3/h is fed to a heat exchanger 
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to be heated to 57°C and then fed to the perforated pan to dry the coating on the tablet. Properties 
of the air flowing into the coater are reflected in Table 13.2.2. The calculations for how the air 
flow was determined can be found in Sections 25.3.1 and 25.3.2. The evaporated water from the 
coating solution and the drying air is removed from the perforated pan through the exhaust. 
Before the tablets leave the system, the heat exchanger is turned off and ambient air is run 
through the system to cool down the tablets to 25°C from 39°C. 
 
Figure 13.2.4. Schematic of Fully Perforated drum for a continuous process. In this 
process, the tablets are coated with a coating solution using multiple spraying arms and 
dried with air [20]. 
 
 
Table 13.2.2. Properties of Air Stream Entering the Continuous Coater 









S-17(C) 25 1.0 6,200 10.0 
S-18(C) 25 1.2 6,200 10.0 
S-19(C) (vessel inlet) 57 1.2 6,800 10.0 
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Section 14: Energy Balance and Utility Requirement  
Section 14.1 Energy Balance and Utility Requirements for the Batch Process  
 14.1.1. Fluid Bed Granulator 
 Energy balances were performed on the overall fluid bed granulation process to 
determine utility requirements. The work required to mechanically run the system was taken to 
equal the motor power of each of the pieces of equipment. Heat analysis was performed to 
determine the heat duty required from the inlet hot air. Granulation is run at ambient temperature 
using airflow at 55°C, and the hot air is cooled down to 25°C through evaporative cooling during 
the process. Granulation operates at saturated conditions, such that humid air enters the system 
and leaves saturated, removing a fraction of the water. The amount of water evaporated during 
granulation is thus determined by inlet air temperature, flow rate, and humidity, as shown in Eqn. 
14.1.1, where ∅𝑠𝑎𝑡 
𝑇𝑓
is the absolute humidity the saturated exhaust air, ∅𝑖 
𝑇𝑖 is the inlet absolute 
humidity (both measure in g water/kg air), and t is time. Heat transfer to the granules themselves 
from the hot air is negligible. The airflow rates and temperatures for granulation were chosen 
based on optimal values found in the literature [17] and confirmed by consultants. An inlet air 
flow rate and temperature of 2,800 m3/h and 55°C were chosen for this process, and steam 
requirements reflect the amount of steam needed to heat 2,800 m3/h of air to 55°C for three 
hours. Steam requirement calculations were conducted using the equations included in Section 
25.3.1 in the appendix. An important assumption made for these calculations is that the pressure 







𝑇𝑓 − ∅𝑖 





Work requirements for the system include the energy required to power the blower, heat 
exchanger and binder pump. The power requirements for the blower motor were modeled using 
equations provided in Seider et al., 2017, and calculations can be shown in section 25.3.1.  Due 
to low binder volumetric flow rates, a peristaltic pump is used to introduce the binder fluid to the 
system. An industrially available pump was selected, and utility requirements were obtained 
from the equipment manual. Motor energy required for the fluid bed granulator was taken as 
given from a representative at Glatt, who provided equipment cost and utility specifications for 
the vessel, independent of the heat exchanger, blower, and pump systems. Heat exchanger 
electricity requirements were determined through modeling in Aspen Plus, after all heat duty 
calculations were performed. It is important to note that even though GR-1(B)/DR-1(B) 
represents one piece of equipment, energy balances and utility calculations were performed for 
the granulation and drying unit operations separately. The same applies for the use of BL-1(B) 













Table 14.1.1. Utilities for Batch Granulation 






GR-1(B) - - 159 Glatt 
Representative 
HX-1(B) 105 - 156 Aspen 
BL-1(B) - - 67 Seider, et al. 
PM-1(B) - 304 0 Equipment 
Brochure 
Total 105 304 382  
 
 
Section 14.1.2 Fluid Bed Dryer 
 Fluid bed drying occurs in the same vessel as fluid bed granulation, and energy balances 
and utility requirements were calculated accordingly. There is no pumping involved in the drying 
process. Most of the heat provided to the system from the hot inlet air is used to evaporate the 
water. The rest is used to heat the vessel and granules to the final operating temperature of 40ºC. 
The equations used to model this system can be found in Section 25.3.2. Once the heat duty was 
determined, it was possible to determine the mass and volumetric flow rate of air necessary for 
operation. From this, the mass flow and volumetric flow of air was calculated, thus allowing for 
calculation of steam utility requirements (see Section 25.3.2). It is assumed that the remainder of 
the water was evaporated during drying. Drying occurs below saturation temperatures, and the 
absolute humidity of the exhaust stream was calculated using equation 14.1.2. 
 
∅𝑓
𝑇2 =  
(𝑚𝑤𝑎𝑡𝑒𝑟,𝑡𝑜𝑡 − 𝑚𝑤𝑎𝑡𝑒𝑟,𝑔𝑟𝑎𝑛) 





Blower motor power was determined, once again, using correlations reported in Seider et al., 
2017. 
Table 14.1.2. Utilities for Batch Drying 
Equipment Steam (kg/batch) Motor Power 
(kWh/batch) 
Motor Power Source 
DR-1(B) - 319 Glatt Representative 
HX-1(B) 527 312 Aspen 
BL-1(B) - 245 Seider, et al.  




During milling, heat is produced due to the rotation of the milling chamber and 
subsequent particle movement through the screen around the chamber. Energy balances were 
used to calculate the amount of heat dissipated into the material during milling. The temperature 
rise in the material if all the heat produced is absorbed by the material was calculated by using an 
estimated value for the heat capacity of the material. Some of the heat produced could instead be 
released into the surroundings. Based on a recommendation from the project author, the API and 
excipients were assumed to have the properties of water. Also, the mill rotational speed was 
assumed to be 700 RPM to prevent the generation of fines. 
 Based on a recommendation from our project author, any value of temperature rise below 
10°C was considered acceptable. The value of this temperature rise was found to be 
approximately 3°C, which was reasonable and would not adversely affect the quality of the 
batch. The motor drive energy requirement was 3.73 kW, which was obtained for the Quadro 
 83 
FlexSift S20 from a Quadro sales representative. Detailed energy balance calculations are in the 
Section 25.3.3. 
 
Table 14.1.3. Utilities for the Batch Mill 




ML-1 (B) 11.2 Quadro 
 
 
14.1.4 Bin Blender 
During blending, heat is produced due to the mixing of API and excipients. Energy 
balances were used to calculate the amount of heat dissipated into the material during blending. 
The temperature rise in the material if all the heat produced is absorbed by the material was 
calculated by using an estimated value for the heat capacity of the material. Some of the heat 
produced could instead be released into the surroundings. The API and excipients were assumed 
to have the properties of water. Also, the blender rotational speed was assumed to be 5 RPM 
because of the large batch size of 2000 kg. The larger the batch size, the lower the rotational 
speed of the blender [8]. 
Based on a recommendation from our project author, any value of temperature rise below 
10°C was considered acceptable. The values of the temperature rise for the pre-blender and 
blender were found to be approximately 6.6°C and 5°C respectively. These values are reasonable 
and would not adversely affect the quality of the batch. The motor drive energy requirements for 
both blenders were 25.5 kW, obtained from an LB Bohle sales representative for an LB Bohle 
container blender (PM-6000) with an overall capacity of 6000 L. The working volume of the 
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blender is 5100 L, which is 85% of the overall capacity to account for the headspace needed in 
the blender. Detailed energy balance calculations are in Section 25.3.4.  
 
 
Table 14.1.4 Utilities for Batch Blender 




BL-1 (B) 17 LB Bohle 
BL-2 (B) 17 LB Bohle 
 
 
14.1.5 Rotary Tablet Press 
During compression, the compression force is one of the tablet press parameters. Work is 
done on the powder to form a tablet by the compression force and heat is released by the system 
during this process. Section 25.3.5 shows how the energy released by the system can be 
calculated. The system is the powder in the die. Work is done on the system by the compression 
force, and heat is released instead of absorbed by the system. To find the heat released by the 
system, the heat capacity of the powder blend and temperature change is required. The API and 
excipients are assumed to have the same heat capacity as water as described in Section 11. 
Additionally, the work done by the compression force can be calculated from the compression 
force and the turret speed. The properties of the tablet press that were used for these calculations 
were obtained from a research article by Nayak et al [39]. The calculations for energy of the 
tablet press can be found in Section 25.3.5. According to GEA, the consumption of the 
MODUL™ P Tablet Press is 6 kW. The motor power for the tablet press was found using this 
information from GEA and can be found Table 14.1.5.  
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Table 14.1.5 Utilities for the Compressor for the 
Batch Process 




TP-1(B) 126 GEA 
 
14.1.6 Batch Fully Perforated Pan 
A thermodynamic model of the tablet coater allowed for determination of the heat loss of 
the system by evaluating the enthalpy change of the processing air, and the enthalpy change of 
the coating. For this calculation, it was assumed that 90% of the coating solution is water and 
that all the water is evaporated during drying. These calculations can be found in Section 25.3.6. 
The optimal airflow rate and temperature for coating were determined to be 17,900 m3/h and 
75°C respectively, and steam requirements reflect the amount of steam needed to heat 17,900 
m3/h of air to 75°C for 6 hours. These calculations are conducted similarly to the calculations for 
the fluid bed granulator, detailed in Section 25.3.1.  
Other energy input requirements to the system include the energy required to power the 
heat exchanger, blowers, and to pump the coating solution into the tablet coater. The amount of 
steam required for HX-2(B) was found the same way that it was found for the fluid bed 
granulator as described in section 14.1.1. The power requirements for the blower motors were 
modeled using equations provided in Seider et al., 2017. Similar to the fluid bed granulator, the 
coating solution flow rates are low. Therefore, a peristaltic pump is used to introduce the coating 
solution to the system. It was determined that the best pump for this operation is a 
pharmaceutical pump, Verderflex Vantage 3000 P EZ Model. This pump’s specifications fall 
within what is required for this process, as detailed in section 15, and the prescribed motor power 
of this piece of equipment was used as the electricity requirement. According to a Thomas 
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Engineering representative, the motor power required for the batch tablet coater is 5.6 kW. Table 
14.1.6 summarizes the utility requirements for the batch tablet coater.  
 
Table 14.1.6. Utilities for the Batch Tablet Coater 






TC-1(B) - 711 8.94 Thomas 
Engineering 
PM-2(B) - - 0 Equipment 
Brochure 
HX-2(B) 1686 - 312 Aspen 
BL-2(B) - - 2756 Seider et al. 
Total 1686 711 2077  
 
 
Section 14.2 Energy Balance and Utility Requirements for the Continuous Process 
14.2.1. Continuous Twin Screw Granulation 
 In contrast to the fluid bed granulator used for the batch process, the twin screw 
granulator does not require the use of fluidizing air or heat input. Thus, the only utility 
requirements to the system are motor power and process water, and energy balances can 
otherwise be ignored. Motor power requirements were obtained from a representative at Thermo-







Table 14.2.1. Utilities for the Continuous Granulator 




Motor Power Source 
GR-1(C) - 264 Thermo-Fisher 
Representative 
PM-1(C) 192 0 Equipment Brochure 
Total 192 264  
 
 
14.2.2 Continuous Fluid Bed Dryer 
 Calculations were performed using the same methods presented in section 14.1.2 for the 
fluid bed dryer. Results from these calculations are tabulated below for the continuous process. 
Energy required to heat the vessel is neglected in these calculations, as the continuous vessel will 




Table 14.2.2. Utilities for the Continuous Dryer 
Equipment Steam (kg/day) Motor Power 
(kWh/day) 
Motor Power Source 
DR-1(C) - 288 Glatt Representative 
HX-1(C) 264 1248 Aspen 
BL-1(C) - 113 Seider, et al.  
Total 690 1,649  
 88 
14.2.3 Milling 
 Like milling in the batch process, energy balances for milling in the continuous process 
were used to calculate the amount of heat dissipated into the material during milling. The 
temperature rise in the material if all the heat produced is absorbed by the material was 
calculated by using an estimated value for the heat capacity of the material. Some of the heat 
produced could instead be released into the surroundings. The API and excipients were assumed 
to have the properties of water. Also, the mill rotational speed was assumed to be 700 RPM to 
prevent the generation of fines. 
 Based on a recommendation from our project author, any value of temperature rise below 
10°C was considered acceptable. The value of this temperature rise was found to be 
approximately 4°C, which was reasonable, and would not adversely affect the quality of the 
material. The motor drive energy requirement was 3.73 kW, which was obtained for the Quadro 
FlexSift S20 from a Quadro sales representative. However, the motor drive energy used in 
calculations was 0.55 kW because a lower amount of energy is needed to mill the lower 
throughput for the continuous process. The amount of material present at any given time in the 
mill in the continuous process is lower than that in the batch process. Therefore, a lower amount 
of energy is required to mill the lower amount of material. Detailed energy balance calculations 
are in Section 25.3.3. 
 
Table 14.2.3. Utilities for the Continuous Mill 








14.2.4 Continuous Blender 
Similar to calculations for the batch blending process, energy balances were used to 
calculate the amount of heat dissipated into the material during continuous blending. The 
temperature rise in the material assuming that all the heat produced was absorbed by the material 
was calculated by using an estimated value for the heat capacity of the material. However, it is 
possible that some of the heat produced could instead be released into the surroundings. Also, the 
blender rotational speed was assumed to be 25 RPM because the amount of material present in 
the blender at any given time is smaller than that in the bin blender. A higher blender rotational 
speed is needed to blend this smaller amount of material [8].  
 Based on a recommendation from our project author, a temperature rise below 10°C was 
considered acceptable. The values of the temperature rise for the pre-blender and blender were 
found to be approximately 2°C and 1.5°C respectively, which was reasonable, and would not 
adversely affect the quality of the material. The motor drive energy requirement was 0.37 kW, 
which was obtained for a Gericke GCM-450 continuous blender. Detailed energy balance 
calculations are in Section 25.3.4. 
 
 
Table 14.2.4. Utilities for the Continuous Blender 




BL-1 (C) 8.9 Gericke 







14.2.5 Rotary Tablet Press 
The same tablet press is used for both the batch and continuous process. The energy of 
the tablet press was found the same way as described in section 14.1.5. For the continuous 
process, calculations for the energy of the tablet press can be found in Section 25.3.5. The motor 
power for the tablet press was also found from contacting a vendor from GEA and this is shown 
in Table 14.2.5. 
 
Table 14.2.5 Utilities for Compression for the 
Continuous Process 




TP-1 144 GEA 
 
14.2.6 Continuous Fully Perforated Pan 
A thermodynamic model similar to that used for the batch process (Section 14.1.6) can 
also be used for the continuous process. The fully perforated continuous tablet coater would use 
a process air volume of 6,800 m3/h and this can be used to determine the enthalpy change of the 
processing air. Additionally, a publication from Thomas Engineering, shown in Section 
25.10.11, provides information on the temperature of the inlet air, the temperature of the 
exhausts and the product temperature. Information from the material balances from Section 12 is 
used for these calculations. According to a Thomas Engineering representative, the motor power 
required for the continuous tablet coater is 1.5 kW. Other utility calculations were calculated the 





Table 14.2.6. Utilities for the Continuous Coater 






TC-1(C) - 29.7 35.8 Thomas 
Engineering 
PM-2(C) - - 0.3 Seider et al. 
HX-2(C) 113 - 1248 Aspen 
BL-2(C) - - 4210 Seider et al. 


























Section 15: Equipment List and Unit Descriptions 
 
Section 15.1 Equipment List and Unit Descriptions for the Batch Process 
 
15.1.1 Fluid Bed Granulator  
 
 Granulation and drying occur in one singular equipment vessel for this process. This was 
designed with the intent to reduce capital costs. A highly regarded industrially used vessel from 
Glatt, the GCCG Pro 30 Fluid Bed Dryer Granulator, was chosen as a model piece of equipment 
for this process. Capital cost estimates for the entire system were obtained, however the heat 
exchanger, pumps, and fans were designed independently to determine the utility requirements 
accurately. Due to the small binder flow rate in the pump, a peristaltic pump is required and the 
Venderflex Vantage 300 P EZ was chosen for this system due to its compatible specifications 
and recorded use in pharmaceutical applications. The motor power required for the pump was 





Type Fluid Bed Granulator and Dryer 
Material Stainless Steel 
Operating Temperature 25ºC /40ºC 
Pressure 1 atm 
Motor Power 53 kW 
Specification Sheet Section 16.1.1 







Type Counter-Current Heat Exchanger 
Material Stainless Steel 
Pressure 1 atm 
Motor Power 52 kW 
Specification Sheet Section 16.1.2 
Design Calculations Section 25.4.1  
Unit BL-1(B) 
Type Centrifugal Blower 
Material Stainless Steel 
Motor Power 22/41 kW 
Specification Sheet Section 16.1.4 
Design Calculations Section 25.3.1 
Unit PM-1(B) 
Type Peristaltic Pump 
Material Stainless Steel 
Pressure 1 atm 
Motor Power Negligible  
Specification Sheet 16.1.3 
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15.1.2 Fluid Bed Dryer  
 















































The primary purpose for milling in this process is delumping and particle 
deagglomeration. The mill will be run at the least possible aggressive conditions to reduce fines 
generation. The Quadro FlexSift S20 was selected as it can gently delump the particles without 
particle size reduction and with very low fines generation. This equipment can also remove any 
impurities present in the material. 
 This equipment consists of a powder processing head attached to an interface for 
controlling the RPM at which the system is operating, and a motor for providing energy for the 
rotation of the milling chamber. The powder processing head can be changed depending on the 
milling conditions needed for the material. As discussed in Section 10.3, if more aggressive 
milling is required, the FlexSift S20 head can be replaced by the Comil U20 head, which 
improves particle size distributions. Therefore, this equipment is flexible and can handle the 
milling needs for different types of materials. The motor power was obtained by speaking with a 













Material 304 stainless steel, 316 stainless steel for 
product contact parts 
Operating temperature 25°C 
Pressure 1 atm 
Power 3.73 kW 
Specification sheet Section 16.1.5 
Energy balance calculations Section 25.3.3 




15.1.4 Bin Blender 
 
Bin blenders are used in this process. The primary purpose of blending is to lubricate the 
formulation to prevent the tablets from sticking to the punches in the tablet press. A bin blender 
consists of a blending container that is rotated with the help of a drive motor. The rotation of the 
blender causes the particles to be mixed gently with low shear to obtain a uniform mixture. The 








Unit BD-1(B) & BD-2(B) 
Type Batch 
Material AISI 304 Stainless steel 
Operating temperature 25°C 
Pressure 1 atm 
Power 25.5 kW 
Specification sheet Section 16.1.6 
Energy balance calculations Section 25.3.4 
Costing data  Section 17.1 
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15.1.5 Rotary Tablet Press 
The tablet press was selected from a vendor. The tablet press is GEA’s MODUL rotary 
tablet press. The motor power was obtained from GEA. 
Unit TP-1(B) 
Type Tablet Press 
Material Stainless Steel 
Operating Temperature  32°C 
Pressure Change  1 atm  
Motor Power  6 kW 
Specification Sheet Section 16.1.7  
Energy Balance Calculations Section 25.3.5 




15.1.6 Tablet Coater 
The batch tablet coater was selected from a vendor. The batch tablet coater is Thomas 
Engineering’s Accela Cota Pro. Similar to the granulators in Section 15.1.1, capital cost 
estimates for the entire system were obtained by contacting a representative from Thomas 
Engineering, however the heat exchanger, pumps, and blower were designed independently to 
determine the utility requirements accurately. The motor power required for the pump was 
provided by Thomas Engineering. 
Unit TC-1(B) 
Type Batch Fully Perforated Pan 
Material Stainless Steel 
Operating Temperature 45°C 
Pressure Change 1 atm 
Motor Power  5.6 kW 
Specification Sheet Section 16.1.8 
Energy Balance Calculations Section 25.3.6 















Type Counter-Current Heat Exchanger 
Material Stainless Steel 
Pressure 1 atm 
Motor Power 52 kW 
Specification Sheet Section 16.1.9 
Design Calculations Section 25.4.1 
 
Unit BL-2(B) 
Type Centrifugal Blower 
Material Stainless Steel 
Motor Power 113 kW 
Specification Sheet Section 16.1.11 
Design Calculations Section 25.3.1 
 
Unit PM-1 
Type Peristaltic Pump 
Material Stainless Steel 
Pressure 1 atm 
Motor Power Negligible  






Section 15.2 Equipment List and Unit Descriptions for the Continuous Process 
 
15.2.1 Twin Screw Granulator 
 
 The Pharma 24 model Thermo-Fisher twin-screw granulator was chosen for this process, 
as it is suitable for a range of solid throughputs that includes the one demanded by this process. 
Electricity requirements were obtained from a Thermo-Fisher representative over a phone call. 
The same pump model described in section 15.1.1 is for this system. 
Unit GR-1(C) 
Type Continuous Twin-Screw Wet Granulator 
Material Stainless Steel 
Operating Temperature 25ºC 
Pressure 1 atm 
Motor Power 11 kW 
Specification Sheet Section 16.2.1 
Energy Balance Calculations Section 25.3.1  




Type Peristaltic Pump 
Material Stainless Steel 
Pressure 1 atm 
Motor Power Negligible  




15.2.2 Continuous Fluid Bed Dryer 
 
 By recommendation from the twin-screw granulator vendor, a continuous fluid bed 
granulator was selected from the Glatt MODCOS continuous manufacturing line for its 
compatibility with the twin-screw granulator described in section 15.2.1. Consistent with the 
methods described in section 15.1.1, the heat exchanger and blower were designed independently 
of the system to accurately estimate utility requirements. The same assumptions made in section 









Type Continuous Fluid Bed Dryer 
Material Stainless Steel 
Operating Temperature 40ºC 
Pressure 1 atm 
Motor Power 12 kW 
Specification Sheet Section 16.2.3 
Energy Balance Calculations Section 25.3.2 






















Type Centrifugal Blower 
Material Stainless Steel 
Motor Power 5 kW 
Specification Sheet Section 16.2.5 
Design Calculations Section 25.3.1 
Unit HX-1(C) 
Type Counter-Current Heat Exchanger 
Material Stainless Steel 
Pressure 1 atm 
Motor Power 52 kW 
Specification Sheet Section 16.2.4 
Design Calculations Section 25.4.1 
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Section 15.2.3 Mill 
 
 The same equipment is used for milling in both batch and continuous processes as the 
equipment can handle both batch and continuous throughputs. The motor power for the mill in 
the continuous process is lower because of the lower throughput in the continuous process. A 
lower amount of energy is needed to mill the lower throughput to the mill for the continuous 
process. Section 15.1.3 includes further information about the Quadro FlexSift S20. 
Unit ML-1(C) 
Type Continuous 
Material 304 stainless steel, 316 stainless steel for 
product contact parts 
Operating temperature 25°C 
Pressure 1 atm 
Power 0.55 kW 
Specification Sheet Section 16.2.6 
Energy balance calculations Section 25.3.3 




Section 15.2.4 Continuous Blender 
 
Based on the recommendation of our project author, the continuous blender was selected 
for the continuous manufacturing process. Gericke was selected as the equipment manufacturer 
due to its stellar reputation in the pharmaceutical industry. Continuous blenders are tubular in 
design with inputs fed at one end and outputs leaving at the other end. These blenders contain a 
motor-driven shaft present axially in the center of the blender with many blades on the surface of 
the shaft. The rotation of the shaft and blades mixes the inputs added to the blender and 
facilitates the motion of the material through the blender. 
Unit BD-1(C) & BD-2(C) 
Type Continuous 
Material Stainless steel 
Operating temperature 25°C 
Pressure 1 atm 
Power 0.37 kW 
Specification sheet Section 16.2.7 
Energy balance calculations Section 25.3.4 
Costing data  Section 17.1 
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Section 15.2.5 Continuous Tablet Press 
The same tablet press that is used for the batch process, will be used for the continuous 
process. See section 15.1.5.  
Unit TP-1(C) 
Type Tablet Press 
Material Stainless Steel 
Operating Temperature 32°C 
Pressure Change 1 atm 
Motor Power  6 kW 
Specification Sheet Section 16.2.8 
Energy Balance Calculations Section 25.3.5 





Section 15.2.6 Continuous Tablet Coater 
 
The continuous tablet coater was selected from a vendor. The continuous tablet coater is 
Thomas Engineering’s Flex CTC continuous coater. Consistent with the methods described in 
section 15.1.6, the heat exchanger, pump, and blower were designed independently of the system 
to accurately estimate utility requirements. The motor power required for the pump was provided 
by Thomas Engineering. 
Unit TC-1(C) 
Type Continuous Fully Perforated Pan 
Material Stainless Steel 
Operating Temperature 39°C 
Pressure Change 1 atm 
Motor Power  1.5 kW 
Specification Sheet Section 16.2.9 
Energy Balance Calculations Section 25.3.6 




Type Centrifugal Blower 
Material Stainless Steel 
Motor Power 22 kW 
Specification Sheet Section 16.2.12 
Design Calculations Section 25.3.1 
 
Unit PM-1(C) 
Type Peristaltic Pump 
Material Stainless Steel 
Pressure 1 atm 
Motor Power Negligible  






Type Counter-Current Heat Exchanger 
Material Stainless Steel 
Pressure 1 atm 
Motor Power 52 kW 
Specification Sheet Section 16.2.10 










Section 16: Specification Sheets 
 
Section 16.1 Batch Process Specification Sheets  
 
16.1.1. Fluid Bed Granulator and Dryer 
 
While the heat exchangers, blowers, and pumps are included in the capital costs of the 
system, they were each designed independently to accurately approximate utilities based off the 










Description and Function The fluid bed granulator and dryer is a single, large, vessel 
with a working volume of 5,000 L. The vessel is designed 
to be a top-spray granulator, with a nozzle at the top 
through which binder solution is pumped. The vessel is 
equipped with a blower and heat exchanger at the bottom 
through which air travels before it enters through the 
bottom of the chamber at a specified flow rate and 
temperature. The system is also equipped with an air filter 
between the blower and heat exchanger to ensure that only 
clean air enters the system. Exhaust air exits the system 
through the exhaust pipe at the top of the vessel.  
Vendor Glatt 
Operation Batch 
Material Input  API 1,000 kg 
Excipients  540 kg 
Binder Solution 344 kg 
Air 2,800-5,200 m3/h 
Characteristics  Model GCCG Pro 
Construction Materials  Stainless Steel 
Size  5,000 L 
Motor Power 53 kW 
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HX-1(B) Design Data 
Type Shell-in-tube, Countercurrent, Fixed Head 
Effective Surface Area (m2) 0.30-0.95 
LMTD (ºC) 111-99 
Heat Transfer Coefficient (W/m2K) 850 
Tube Side Material Stainless Steel 
Shell Side Material Stainless Steel 
No. Tubes/Pass 1 












HX-1(B)  (Granulation Setting) 
 Cold in Cold out Hot in Hot Out 
Species Air Air Steam Steam 
Temperature (ºC) 25 55 152 152 
Pressure (atm) 2 2 3.4 3.4 
Vapor Fraction 1 1 1 0 
Mass Flow (kg/h) 3,000 3,000 35  35 
Volumetric Flow (m3/h) 2,500 2,800 n/a n/a 
HX-1(B) (Drying Setting) 
 Cold in Cold out Hot in Hot Out 
Species Air Air Steam Steam 
Temperature (ºC) 25 75 152 152 
Pressure (atm) 2 2 3.4 3.4 
Vapor Fraction 1 1 1 0 
Mass Flow (kg/h) 5,200 5,200 81 81 
Volumetric Flow (m3/h) 4,400 5,200 n/a n/a 
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16.1.4 BL-1(B) Air Blower 
 
BL-1(B) Design Data 
Type Centrifugal Blower 
Material Stainless Steel  
Blower Efficiency 0.75 
Motor Efficiency 0.92 
 
BL-1(B) Granulator Settings 
Pressure Increase 0.2 atm 
Air Volumetric flow rate 2,800 m3/h 
Power Consumption 90 kW 
 
BL-1(B) Dryer Settings 
Pressure Increase 1 atm 
Air Volumetric flow rate 5,200 m3/h 















Description and Function Peristaltic pump used to pump binder solution in the 
granulator during granulation. Modeled separately to 
accurately estimate utility costs.   
Vendor Venderflex 
Operation Batch 
Material Input  Binder Solution (12%) 10 kg/h 
Characteristics  Model Vantage 3000 
Construction Materials  Stainless Steel 
Capacity 0.9 mL/min to 1.21 L/min 
Motor Power 0.02 kW 
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16.1.5 ML-1(B) Mill 
 
It should be noted that milling is a semi-continuous operation, and that the duration of 
milling for the batch process is three hours. Therefore, the throughput from the mill is 





Description and Function This equipment consists of a powder processing head, which is 
attached to the SMARTdetect Interface that controls and 
automatically adjusts the RPM at which the system is operating. 
The head also contains a gearbox inside it. The interface is 
attached to a motor that provides energy for the rotation of the 
milling chamber. The control panel is present below the motor 
and can be used by the operator to set the mill rotational speed. 
Vendor Quadro 
Operation Batch 
Materials Handled  Input (kg) Output (kg) 
API 1000 1000 
Excipients 560 560 
Characteristics  Model Quadro FlexSift S20 
Construction 
Materials  
304 stainless steel, 316 stainless steel 
product contact parts 









Motor Power 3.73 kW 
 115 
16.1.6 BD-1(B) & BD-2(B) Bin Blender 
 
The LB Bohle container blender (PM-6000) is filled to 85% of its total capacity as 
headspace is required for blending to be carried out properly. 
 
  
BD-1(B) & BD-2(B) 
Description and 
Function 
There are two blenders in the batch process—one pre-blender before 
the granulator, and one blender after the mill. The same model is 
used for both. This equipment consists of a clamping cage to hold the 
blend container during operation and a motor that provides energy 
for the rotation of the container. A control panel is present near the 
equipment for the operator to set parameters such as the blender 
rotational speed.  
Vendor LB Bohle 
Operation Batch 
Materials Handled For BD-1(B): 
 Input 1 (kg) Input 2 (kg) Output (kg) 
API 1000 0 1000 
Excipients 0 520 520 
For BD-2(B): 
 Input 1 (kg) Input 2 (kg) Output (kg) 
API 1000 0 1000 
Excipients 560 360 920 




Size for both 
blender and pre-
blender 
6000 L  
Motor Power 25.5 kW 
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16.1.7 TP-1(B) Rotary Tablet Press 
 
It should be noted that compression is a continuous operation, and that the duration of 
compression for the batch process is 21 hours. Therefore, the throughput from the tablet press is 
approximately 91 kg/h. 
 
TP-1(B) 
Description and Function The MODUL™ P rotary tablet press compresses the powder 
(API and excipient) blend into tablets. The characteristics of 
this equipment were obtained from GEA’s website for the 
MODUL™ P rotary tablet press. 
Vendor GEA 
Operation Compression 
Material Input  Powder blend 1920 kg 
Characteristics  Model MODUL™ P rotary tablet 
press 
Construction Materials  Stainless Steel  
Size  W = 1030 mm x D = 1555 
mm x H = 2170 m – 2.500 kg 




16.1.8 TC-1(B) Batch Tablet Coater 
 
The heat exchangers, blowers, and pumps are included in the capital costs of the system, 
but they were each designed independently to accurately approximate utilities based off the 
demanded design specifications and are thus reported independently below. 
TC-1(B) 
Description and Function The Thomas Accela-Cota® is a fully perforated coating drum 
that revolutionized the coating manufacturing process when it 
was introduced in 1969. This machine continues to set the 
standards for tablet coating with unrestricted air flow, 
thermodynamic efficiency, and flexibility [55]. The 
characteristics for this tablet coater can be found in the 
equipment brochure (Section 25.10.8). The tablet coater also 
includes a heat exchanger, pump and blower, which are 
designed separately to perform utility calculations.  
Vendor Thomas Engineering 
Operation Tablet Coating 
Material Input  Uncoated Tablets 1920 kg 
 Coating solution 800 kg 
Characteristics  Model Thomas Accela-Cota® 
Construction Materials  Stainless Steel  
Size  W=1,800 mm x H=2,200 mm 
x D =2,550 mm – 2.500 kg 
Motor Power 5.6 kW 
  
 118 
16.1.9 HX-2(B) Heat Exchanger 
 
  
HX-2(B) Design Data 
Type Shell-in-tube, Countercurrent, Fixed Head 
Effective Surface Area (m2) 3.4 
LMTD (ºC) 99 
Heat Transfer Coefficient (W/m2K) 850 
Tube Side Material Stainless Steel 
Shell Side Material Stainless Steel 
No. Tubes/Pass 1 
No. Passes 1 
HX-2(B) Settings 
 Cold in Cold out Hot in Hot Out 
Species Air Air Steam Steam 
Temperature (ºC) 25 75 152 152 
Pressure (atm) 2 2 3.4 3.4 
Vapor Fraction 1 1 1 0 
Mass Flow (kg/h) 18,100 18,100 281 281 
Volumetric Flow (m3/h) 15,300 17,900 n/a n/a 
 119 
16.1.10 PM-2(B) Coater Pump  
 
See Section 16.1.3 
 
16.1.11 BL-2(B) Coater Air Blower 
 
BL-2(B) Design Data 
Type Centrifugal Blower 
Material Stainless Steel  
Blower Efficiency 0.75 
Motor Efficiency 0.92 
 
BL-2(B) Settings 
Pressure Increase 0.2 atm 
Air Volumetric flow rate 17,900 m3/h 






























Section 16.2 Continuous Process Specification Sheets  
 
16.2.1. GR-1(C) Twin Screw Granulator 
 
While the heat exchangers, blowers, and pumps are included in the capital costs of the 
system, they were each designed independently to accurately approximate utilities based off the 




16.2.2 PM-1(C) Binder Pump 
 















Description and Function The continuous twin-screw wet granulator is composed of 
two co-rotating screws enclosed in a barrel. There are two 
kneading zones separated by conveying zones. Geometry 
of the kneading and conveying screw elements is 
customizable, and screw speed can be set. The equipment 
comes with feeders, a pump for the binder fluid, and an 
automated interface.  
Vendor Thermo Fisher Scientific  
Operation Continuous 
Material Input  API 41 kg/h 
Excipients  21 kg/h 
Binder Solution 10 kg/h 
Characteristics  Model GCCG Pro 
Construction Materials  Pharma 24 
Capacity 70-85 kg/h 
Motor Power 20 kW 
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Description and Function The continuous fluid bed dryer comes complete with 
blowers and heat exchangers to blow air in from 
underneath the vessel to dry the moving granules at 
specified temperatures and volumetric flow rates. Solids 
are transported pneumatically through the system and are 
fluidized by the hot air during drying. Exhaust air exits 
through exhausts pipes out the top of the vessel. 
Vendor Glatt 
Operation Continuous  
Material Input  API 41 kg/h 
Excipients  23 kg/h 
Air 1,200 m3/h 
Characteristics  Model MODCOS l-line 
Construction Materials  Stainless Steel 
Capacity 50-100 kg/h 
Motor Power 12 kW 
HX-1(C)  Settings 
 Cold in Cold out Hot in Hot Out 
Species Air Air Steam Steam 
Temperature (ºC) 25 55 152 152 
Pressure (atm) 2 2 3.4 3.4 
Vapor Fraction 1 1 1 0 
Mass Flow (kg/h) 1,230 1,230 18 18 
Volumetric Flow (m3/h) 1,040 1,150 n/a n/a 
HX-1(C) Design Data 
Type Shell-in-tube, Countercurrent, Fixed Head 
Effective Surface Area (m2) 0.23 
LMTD (ºC) 99 
Heat Transfer Coefficient (W/m2K) 850 
Tube Side Material Stainless Steel 
Shell Side Material Stainless Steel 
No. Tubes/Pass 1 
No. Passes 1 
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16.2.5 BL-1(C) Air Blower  
BL-1(C) Design Data 
Type Centrifugal Blower 
Material Stainless Steel  
Blower Efficiency 0.75 
Motor Efficiency 0.92 
 
BL-1(C) Settings 
Pressure Increase 0.1 atm 
Air Volumetric flow rate 1,200 m3/h 
Power Consumption 37 kW 
 
16.2.6 ML-1(C) Mill 
 
The motor power for the mill in the continuous process is lower because of the lower 
throughput in the continuous process. A lower amount of energy is needed to mill the lower 
throughput to the mill for the continuous process. 
 
ML-1(C) 
Description and Function The same equipment is used for both the batch and continuous 
process. This equipment consists of a powder processing head, 
which is attached to the SMARTdetect Interface that controls and 
automatically adjusts the RPM at which the system is operating.  
The head also contains a gearbox inside it. The interface is 
attached to a motor that provides energy for the rotation of the 
milling chamber. The control panel is present below the motor 
and can be used by the operator to set the mill rotational speed. 
Vendor Quadro 
Operation Continuous 
Materials Handled  Input (kg/hr) Output (kg/hr) 
API 41 41 
Excipients 23 23 
Characteristics  Model Quadro FlexSift S20 
Construction 
Materials  
304 stainless steel, 316 stainless steel 
product contact parts 









Motor Power 0.55 kW 
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BD-1(C) & BD-2(C) 
Description and 
Function 
Similar to the batch process, there are two blenders in the continuous 
process—one pre-blender before the granulator, and one blender after 
the mill. The same model is used for both. This equipment consists of 
a tubular continuous mixing module with feeders for the inputs to the 
blender. It also contains a motor that provides energy for the rotation 
of the shaft located axially in the center of the blender with blades 
covering its surface. Blend homogeneity is tested using a near-infrared 
(NIR) probe present at the output end of the mixer. 
Vendor Gericke 
Operation Continuous 
Materials Handled For pre-blender: 
 Input 1 (kg/hr) Input 2 (kg/hr) Output (kg/hr) 
API 41 0 41 
Excipients 0 21 21 
    
For blender: 
 Input 1 (kg/hr) Input 2 (kg/hr) Output (kg/hr) 
API 41 0 41 
Excipients 23 15 38 







Length (m) 1.8 
Width (m) 1.6 
Height (m) 1.65 
Size of mixing 




Motor Power 0.37 kW  
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16.2.8 TP-1(C) Rotary Tablet Press 
 
TP-1(C) 
Description and Function The MODUL™ P rotary tablet press compresses the powder 
(API and excipient) blend into tablets. The characteristics of 
this equipment were obtained from GEA’s website for the 
MODUL™ P rotary tablet press.  
Vendor GEA 
Operation Compression 
Material Input  Powder blend 79 kg/hr 
Characteristics  Model MODUL™ P rotary tablet 
press 
Construction Materials  Stainless Steel  
Size  W = 1030 mm x D = 1555 
mm x H = 2170 m – 2.500 kg 




16.2.9 TC-1(C) Continuous Tablet Coater  
 
While the heat exchangers, blowers, and pumps are included in the capital costs of the 
system, they were each designed independently to accurately approximate utilities based off the 
demanded design specifications and are thus reported independently below. 
TC-1(C) 
Description and Function The Thomas Flex CTC® Continuous Tablet Coater extends 
film coating technology from the typical batch process to a 
fast and efficient continuous process. The characteristics for 
this tablet coater can be found in the equipment brochure 
Section 25.10.10. The tablet coater also includes a heat 
exchanger, pump, and blower, which are designed separately 
to perform utility calculations. This equipment has 22 spray 
nozzles that introduce the coating solution to the tablets and 
also includes a wash-in-place system [16]. 
Vendor Thomas Engineering 
Operation Tablet Coating 
Material Input  Uncoated Tablets 79 kg/hr 
 Coating solution 33 kg/hr 
Characteristics  Model Thomas FLEX CTC® 
Continuous Tablet Coater 
Construction Materials  Stainless Steel  
Size  15’3” ft x 4’2” ft x 10’9” ft [ 
4.57m x 1.21m x 3.04m] 
Motor Power 1.5 kW 
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16.2.10 HX-2(C) Heat Exchanger 
 
 
16.2.11 PM-2(C) Coater Pump  
 
See Section 16.1.3  
HX-2(C) Design Data 
Type Shell-in-tube, Countercurrent, Fixed Head 
Effective Surface Area (m2) 0.67 
LMTD (ºC) 110 
Heat Transfer Coefficient (W/m2K) 850 
Tube Side Material Stainless Steel 
Shell Side Material Stainless Steel 
No. Tubes/Pass 1 
No. Passes 1 
HX-2(C) Settings 
 Cold in Cold out Hot in Hot Out 
Species Air Air Steam Steam 
Temperature (ºC) 25 57 152 152 
Pressure (atm) 2 2 3.4 3.4 
Vapor Fraction 1 1 1 0 
Mass Flow (kg/h) 7,300 7,300 113 113 
Volumetric Flow (m3/h) 6,200 6,800 n/a n/a 
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16.2.12 BL-2(C) Coater Air Blower 
 
BL-2(C) Design Data 
Type Centrifugal Blower 
Material Stainless Steel  
Blower Efficiency 0.75 
Motor Efficiency 0.92 
 
BL-2(C) Settings 
Pressure Increase 0.1 atm 
Air Volumetric flow rate 6,800 m3/h 


















Section 17: Equipment Summary 
Section 17.1 Equipment Purchase Cost 
For the economic analysis, the purchase price of the equipment was a strong influence on 
the determined profitability of each process. SuperPro Designer was used to estimate the costs 
for the different pieces of equipment that are used for both processes. Upon assessment, it was 
determined that the values provided by SuperPro were not realistic. Additionally, when 
developing models on SuperPro, some of the equipment needed for the process was not available 
to add to the model. This was a greater problem for the continuous model, as SuperPro had no 
options for modeling the twin screw granulator and blender. It was decided that it would be best 
not to rely on the values for purchase costs given by SuperPro.  
Concepts and correlations from Seider et al.’s textbook were used to calculate purchase 
costs of the different pieces of equipment (Section 25.6). These prices were significantly lower 
than vendor quotes, as shown in Table 17.1.1 and Table 17.1.2. A reason for the inaccuracy of 
these values could be the assumptions made to perform the calculations, as the correlations were 
used even when the size factors for the equipment were outside the suitable range. For some 
equipment, no correlations were available. Thus, the correlations assumed to model those pieces 
of equipment were not reflective of the actual equipment used in the processes, as shown in 
Section 25.6.  
Purchase cost estimates were also obtained from industrial vendors. It was difficult to 
contact some vendors, and some could not give exact estimates due to confidentiality. In some 
cases, the quotes given for the equipment did not match our batch size or throughput. To get a 
price that was more suitable for the equipment in our processes, the vendor equipment cost was 
scaled using the sixth-tenths rule. Additionally, literature and reseller websites were also helpful 
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sources for obtaining purchase prices. For all the process equipment with multiple vendor quotes, 
the most precise and reliable vendor was selected. Table 17.1.1 and Table 17.1.2 summarize all 
the sources that were used to obtain purchasing cost information and explain which prices were 
used for the economic analysis and why. For most of the equipment, prices from vendors were 
used, as they appeared to be the most reliable, and those prices were scaled appropriately when 
necessary. Table 17.1.2 also includes a cost for conveying, and information on how this cost was 
calculated can be found in Section 25.6.6. 
After each process is complete, the tablets are stored in Rhino BV-60 bins. Each bin has a 
volume of 2,500 L, and it was suggested that about 2,000 L of tablets should be stored in a 
singular bin to avoid crushing the tablets. Since both processes produce the same number of 
tablets, about 4,000 L/day for the batch process and 3,940 L/day for the continuous process, two 
bins would be needed per day for each process to store the tablets. A bulk density of 0.5 kg/L 
was used to determine these volumes. The cost of the storage bins is included as a one-time 
equipment purchase cost in the profitability analyses. However, storage bins would need to be 
purchased annually. As the same number of bins are required for both processes, cost of the bins 
will not affect the results of the economic analyses when comparing the batch and continuous 
processes. Also, the costs of the bins are small compared to the costs of other pieces of 
equipment and do not significantly affect the profitability analyses. Tabulated purchase costs do 
not include pumps, heat exchangers and blowers as they are included in the purchase cost 
estimates for the granulators, dryers, and coaters, and were only modeled separately to estimate 
utility requirements. 
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 Table 17.1.1 shows that the total purchase cost for the batch process would be 























Table 17.1.1 Purchase Costs for Equipment for the Batch Process 
 
Table 17.1.2 Purchase Costs for Equipment for the Continuous Process 
 

















value($) Reasons for selected values
Granulator 
+
Dryer 23,611,000 267,000 3,500,000 1,920,000 1,000,000 1,238,321 3,500,000
A Glatt representative provided a 
reliable quote. Other vendors provided 
rough estimates
Pre-
Blender 6,919,500 30,000 140,000 700,000 - 410,222 700,000
LB Bohle representative provided 
reliable quote
Blender 6,919,500 30,000 140,000 700,000 - 410,222 700,000
LB Bohle representative provided 
reliable quote
Mill 171,000 20,000 45,000 55,000 65,500 200,411 45,000
Quadro representative provided 
reliable quote
Tablet 
Press 708,000 32,000 196,000 510,000 - - 510,000
GEA representative provided a reliable 
quote with an associated throughput 
that could be scaled down to match 
the throughput for this process.
Tablet 
Coater 29,450,000 143,000 500,000 - - - 500,000
Thomas Engineering representative 
provided reliable quote
Rhino BV-
60 bins - - 400,000 - - -- 400,000
Bonar Plastics representative provided 
reliable quote
Total $6,355,000
















value($) Reasons for selected values
Granulator 36,000 78,000 735,000 1,000,000 - 650,000 1,000,000
Thermo-Fisher representative provided 
reliable quote
Dryer 3,058,000 92,000 196,500 - - 45,000 196,500
Glatt representative provided a reliable quote 
with an associated throughput that could be 
scaled down to match the throughput for this 
process.
Pre-Blender 3,058,000 30,000 1,000,000 - - - 1,000,000
Gericke representative provided reliable 
quote
Blender 3,058,000 30,000 1,000,000 - - - 1,000,000
Gericke representative provided reliable 
quote
Mill 68,000 20,000 45,000 55,000 65,500 - 45,000
Quadro representative provided reliable 
quote
Tablet Press 584,000 31,000 196,000 471,000 - - 471,000
GEA representative provided a reliable quote 
with an associated throughput that could be 
scaled down to match the throughput for this 
process.
Tablet Coater 35,000,000 234,000 888,000 - - 725,000 888,000
Thomas Engineering representative provided 
a reliable quote with an associated 
throughput that could be scaled down to 
match the throughput for this process.
Conveying - 25,400 - - - - 25,400 Calculated using Seider et al.
Rhino BV-60 
bins - - 400,000 - - - 400,000




Section 17.2 Equipment Bare Module Cost 
 
Table 17.2.1 and Table 17.2.2 display the equipment purchase costs required for the 
batch and continuous processes respectively. All of the equipment bare module costs were 
obtained using the purchase prices highlighted in Section 17.1, the equations detailed in Seider et 
al.’s “Product and Process Design Principles”, and the CBE 459 Profitability Analysis 4.0 
spreadsheet. The equations used to determine the bare module costs can be found in Section 
25.7. A CE cost index of 600 was used to account for the fact that the index has fluctuated over 




Table 17.2.1 Batch Equipment Cost Summary 



















$45,000 2.30 $103,500 Mill 
BD-2(B) Process 
Machinery 
$700,000 3.21 $2,247,00 Blender 
TP-1(B) Process 
Machinery 
$510,000 3.21 $1,637,100 Tablet Press 
TC-1(B) Process 
Machinery 
$500,000 3.21 $1,605,000 Tablet Coater 
Rhino BV-60 
bins 
Storage $400,000 1.00 $400,000 Storage Bins 
Total Bare Module Cost: $19,474,600 
 
Table 17.2.2 Continuous Equipment Cost Summary 














$1,000,000 3.21 $3,210,000 Granulator  
DR-1(C) Process 
Machinery 
$196,500 2.06 $404,790 Dryer 
ML-1(C) Process 
Machinery 
$45,000 2.30 $103,500 Mill 
BD-2(C) Process 
Machinery 
$1,000,000 3.21 $3,210,00 Blender 
TP-1(C) Process 
Machinery 
$471,000 3.21 $1,511,910 Tablet Press 
TC-1(C) Process 
Machinery 
$888,000 3.21 $2,850,480 Tablet Coater 
Rhino BV-60 
bins 
Storage $400,000 1.00 $400,000 Storage Bins 
Conveying Other 
Equipment 
$25,427 1.61 $40,937.47 Conveyor 











Section 18: Total Capital Investment Summary 
The Profitability Analysis Spreadsheet 4.0 provided by the course was used to conduct 
economic analyses for our manufacturing facilities. The results obtained from this spreadsheet 
will also be discussed in Sections 19 and 21. 
The equipment purchase costs discussed in Section 17 were inputted into the spreadsheet 
and classified under “Process Machinery” or “Storage”. “Process Machinery”, as defined by 
Seider et al, is equipment that is selected from standard sizes supplied by a vendor and often 
includes a drive motor to satisfy the energy requirement. “Storage” refers to bins that are used to 
store the tablets after production is complete. The bins used for storage are Rhino single wall 
bins (BV-60) from Bonar Plastics. Two bins are used to store a batch (2000 kg) of tablets. All 
other equipment used in both manufacturing processes was classified as process machinery 
because it would be bought from a vendor. 
Section 18.1 Batch Process 
The total bare module costs include purchasing, direct, and indirect installation costs for 
the equipment. For all equipment except the mill, the bare module factors are not known, and so 
the default value of 3.21 given in the spreadsheet was used. For the mill, a bare module factor of 
2.3 computed by Guthrie was used [51]. For the storage bins, a bare module factor of 1 was used 




The default factors given in the spreadsheet were used to calculate the costs of site 
preparation, service facilities, contingencies, land, and startup. There is no cost of royalties as the 
drug being manufactured is a generic drug and is not under any patent. The site factor used was 
1.10, as the plant will be built in New Jersey (U.S. Northeast).  
 
 
 The total permanent investment of the batch manufacturing plant was calculated to be 
$31.1 million. 
 
Table 18.1.1: Total bare module costs for the batch manufacturing facility 




To calculate the working capital, the number of days for accounts receivable and payable 
were set to zero days and 30 days respectively. As the API is obtained from within the company, 
there are no payables on the API. Also, as the tablets are transferred for packaging to another 
facility within the company, there are no receivables on the tablets. The excipients are purchased 
in bulk from a chemical company, Ningbo Samreal Chemical Co. in China, at $1 per bag of 20 
kg [41]. This price was given for magnesium stearate and for simplicity, it is assumed to be the 
same for all excipients needed for the process. The price of excipients can vary based on the type 
of excipients being used in the manufacturing process. The accounts payable for the excipients is 
set to 30 days. The product inventory was set to zero days based on a recommendation from 
Table 18.1.3: Total permanent investment for batch manufacturing facility 
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Professor Vrana. The raw material inventory and cash reserves were kept at the default value of 
two days and 30 days respectively. 
 
 




Table 18.1.4: Factors for calculating working capital 
 
Table 18.1.5: Total capital investment and working capital 
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Section 18.2 Continuous Process 
The same calculations described in Section 18.1 were done for the continuous process. 
Similar to the batch process, the equipment for the continuous process is classified under 
“Process Machinery”. The exceptions are the conveying and storage equipment. The conveyors 
are classified under “Other Equipment”, and the storage bins are classified under “Storage”. Two 
Rhino single wall bins (BV-60) from Bonar Plastics are used to store the tablets made 
continuously in one day. 
The total bare module costs are calculated by multiplying the equipment purchase costs 
by bare module factors. The bare module costs account for purchase, direct, and indirect 
installation costs for the equipment. For the mill, dryer, and conveyor, bare module factors of 
2.3, 2.06, and 1.61 respectively computed by Guthrie were used [51]. For the storage bins, a bare 
module factor of 1 was used as the installation costs for the bins are negligible.  
 
Similar to the batch process, the default factors given in the spreadsheet were used to 
calculate the costs of site preparation, service facilities, contingencies, land, and startup for the 
continuous process. There is no cost of royalties as the drug being manufactured is a generic 
drug and is not under any patent. The site factor used was 1.10, as the plant will be built in New 
Jersey (U.S. Northeast).  




The total permanent investment of the continuous manufacturing facility was calculated 
to be $23.9 million. 
 





To calculate the working capital, the same number of days as the batch process were set 
for accounts receivable, cash reserves, accounts payable, raw material and product inventories. 
 










Table 18.2.4: Factors for calculating working capital 












Section 19: Operating Cost— Cost of Manufacture  
Section 19.1 Operating Costs for the Batch Process 
19.1.1 General Operating Considerations 
 The batch manufacturing plant will be located in New Jersey and will run 24 hours a day, 
330 days per year. Each batch takes 46.5 hours to complete (batch time), but a single batch is 
completed every 24 hours (cycle time). The month off per year will be used for maintenance and 
vacation days. No time needs to be taken off for cleaning because there is enough equipment idle 
time during the batch cycle that the equipment can be cleaned every eight batches without 
interrupting operation. Costs of cleaning have been determined to be negligible, and details are 
available in the appendix. It will take one year to design the facility, one year to build the facility 
and the plant will produce for 21 years. The facility will be designed in 2022, constructed in 
2023, and production will begin in 2024.   
 
19.1.2 Raw materials, Utilities, Byproducts, and General Expenses 
It is assumed that the API is provided without cost to the manufacturing plant. The API to 
excipient ratio by weight (drug load) is 1:1. The excipients are purchased in bulk from a 
chemical company, Ningbo Samreal Chemical Co. in China, at $1 per bag of 20 kg [41]. This 
price was given for magnesium stearate and for simplicity, it is assumed to be the same for all 
excipients needed for the process. The price of excipients can vary based on the type of 





Table 19.1.1 Raw Material Requirements for the Batch Process 
Raw Material Required 
(kg/batch) 
Cost ($/kg) Daily Cost ($) Annual Cost ($) 
API 1,000 0 0 0 
Excipients 1,000 0.05 50 16,500 
 
The utilities used in this process include steam, electricity, and process water. Steam is 
used in each of the heat exchangers, electricity is used to power each piece of equipment, and 
process water is used in both the binder and coating solution. Table 19.1.2 reflects the cost per 
unit of each of the utilities, while Table 19.1.3 reflects the utility requirements for each piece of 
equipment in the process.  
 
Table 19.1.2 Cost of Utilities used in the Batch Process 
Utility Steam, 50 psig (3.4 atm) Water Electricity  




















Table 19.1.3 Utility Requirements for the Batch Process 
Unit Steam (kg/batch) Water (kg/batch) Electricity 
(kWh/batch) 
BD-1(B)   17 
GR-1(B)/DR-1(B)   480 
BL-1(B)   310 
HX-1(B) 630  470 
PM-1(B)  304 0.1 
ML-1(B)   11 
BD-2(B)   17 
TP-1(B)   126 
TC-1(B)   34 
BL-2(B)   680 
HX-2(B) 1,700  310 
PM-2(B)  711 0.12 
Total (per batch) 2,300 1,000 2,500 
Cost (daily) $31 $0 $172 
Cost (annual) $10,097 $90 $56,800 
Total Annual 
Utilities 
  $67,000 
 
There are no byproducts produced by this process that can be sold for profit. General 
expenses include the cost of selling (transfer) expense, direct research, allocated research, 
administrative expense, and management incentive compensation. Costs for each of these 
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categories are calculated using suggestions from Seider, et al., and are shown in Table 19.1.4. 
The target cost per tablet was $0.01, therefore sales are calculated to be $10,000,000 
(1,000,000,000 tablets x $0.01/tablet = $10,000,000). 
 
Table 19.1.4. Variable Cost Summary for the Batch Process 
 
The total variable costs are equal to $1.90 per kg of tablets.  
19.1.3 Fixed Costs—Operations, Maintenance, and Overhead 
 Assumptions used to determine fixed operating, maintenance, and overhead costs are 
sourced from Seider, et al. Table 19.1.5 details the components of fixed operating costs for the 
batch process. For the batch process, it is assumed that four operators are needed per shift, and 
that there are five shifts per day. Two engineers are required at the plant for technical assistance 
and manufacturing, and each are paid $200,000 annually. Additionally, one lab professional is 
needed for the control laboratory and requires a salary of $200,000 annually as well. Table 
19.1.6 details the breakdown of fixed maintenance costs, where TDC stands for Total 
Depreciable Capital (Table 18.1.3). Table 19.1.7 details the breakdown of fixed overhead costs. 
M&O (Maintenance and Operation costs) is defined as the sum of DW&B (Direct Salaries and 
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Benefits) and MW&B (Maintenance Salaries and Benefits). Table 19.1.8 summarizes all fixed 
costs for the batch process.  
 
Table 19.1.5 Components of Fixed Operating Costs for the Batch 
Process 
Operation Details 
Operators Per Shift 4 (assuming 5 shifts) 
Direct Wages and Benefits (DW&B) $40/operator/hour 
Direct Salaries and Benefits 15% of DW&B 
Operating Supplies and Services 6% of DW&B 
Technical Assistance to Manufacturing  $20,000/yr/operator/shift 













Table 19.1.6 Components of Fixed Maintenance Costs for the 
Batch Process 
Operation Details 
Wages and Benefits (MW&B) 4.5% of TDC  
Salaries and Benefits  25% of MW&B 
Materials and Services 100% of MW&B 
Maintenance Overhead 5% of MW&B 
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Table 19.1.7 Components of Fixed Overhead Costs for the Batch 
Process 
Operation Details 
General Plant Overhead 7.1% of M&O 
Mechanical Department Services 2.4% of M&O 
Employee Relations Department 5.9% of M&O 






Table 19.1.8. Summary of All Fixed Costs for the Batch Process  
 
 
The total fixed costs are equal to $9.84 per kg of tablets. 
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Section 19.2 Operating Costs for the Continuous Process 
19.2.1 General Operating Considerations 
 The continuous manufacturing plant will be in New Jersey and will run 24 hours a day, 
330 per year. A continuous throughout of 82 kg/h will be used to produce 2,000 kg of tablets per 
day and meet the annual demand of one billion tablets. The month off per year will be used for 
maintenance, cleaning, and vacation days. The process will have to be shut down for cleaning the 
equipment. A target process run length before cleaning was estimated by doing a sensitivity 
analysis, as explained in Section 20.4. The exact amount and cost of the cleaning agent required 
will be optimized by a process R&D team and is out of scope for this report. It will take one year 
to design the facility, one year to build the facility, and the plant will produce tablets for 21 
years. The facility will be designed in 2022, constructed in 2023, and production will begin in 
2024.  
 
19.2.2 Raw materials, Utilities, Byproducts, and General Expenses 
It is assumed that the API is provided without cost to the manufacturing plant. The API to 
excipient ratio by weight (drug load) is 1:1. Details about excipient pricing are included in 
Section 19.1.2. Table 19.2.1 details the raw material requirements for the continuous process.  
Table 19.2.1 Raw Material Requirements for the Continuous Process 
Raw Material Required (kg/hr) Cost ($/kg) Daily Cost ($) Annual Cost ($) 
API 41 0 0 0 
Excipients 41 0.05 50 16,500 
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The utilities used in this process include steam, electricity, and process water. Steam is 
used in each of the heat exchangers, electricity is used to power each piece of equipment, and 
process water is used in both the binder and coating solution. Table 19.2.2 reflects the cost per 
unit of each of the utilities, while Table 19.2.3 reflects the utility requirements for each piece of 
equipment in the process.  
Table 19.2.2 Cost of Utilities used in the Continuous Process 
Utility Steam, 50 psig (3.4 atm) Water Electricity  




Table 19.2.3 Utility Requirements for the Continuous Process 
Unit Steam (kg/h) Water (kg/h) Electricity (kWh/day) 
BD-1(C)   9 
GR-1(C)   480 
PM-1(C)  8.1 0.5 
DR-1(C)   288 
BL-1(C)   113 
HX-1(C) 18  1,248 
ML-1(C)   13 
BD-2(C)   9 
TP-1(C)   144 
TC-1(C)   36 
BL-2(C)   537 
HX-2(C) 113  1,248 
PM-2(C)  30 0.5 
Total (per hour) 131 37.8 4,126 
Cost (daily) $42 $0 $288 
Cost (annual) $13,695 $81 $95,303 
Total Annual 
Utilities 
  $109,080 
 
There are no byproducts produced by this process that can be sold for profit. General 
expenses include the cost of selling (transfer) expense, direct research, allocated research, 
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administrative expense, and management incentive compensation. Costs for each of these 
categories are calculated using suggestions from Seider, et al., and are shown in Table 19.2.4. 
The target cost per tablet was $0.01, therefore sales are calculated to be $10,000,000 
(1,000,000,000 tablets x $0.01/tablet = $10,000,000). 
 
Table 19.2.4 Variable Cost Summary for the Continuous Process 
 
The total variable costs are equal to $1.97 per kg of tablets.  
19.2.3 Fixed Costs—Operations, Maintenance, and Overhead 
 Assumptions used to determine fixed operating, maintenance, and overhead costs are 
sourced from Seider, et al., and follow the same outline as shown in Tables 19.1.5-19.1.7, with 
the exception that for the continuous process, it is assumed that only three operators are required 
per shift as opposed to the four per shift required for the batch process. A summary of all the 
fixed costs required for the continuous process is shown in Table 19.2.5. 
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Table 19.2.5. Fixed Cost Summary for the Continuous Process 
 
 
The total fixed costs are equal to $7.82 per kg of tablets. 
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Section 19.3 Interpretation of Operating Costs  
 
 Through evaluation of the tables presented above, operating costs are greater for the 
batch process than the continuous process. The sum of utilities, general expenses, and fixed costs 
for the batch process and continuous processes are about $7.7 million and $6.2 million 
respectively. Utility costs are higher for the continuous process than the batch process likely due 
to constant operation of the equipment in the continuous process. In the batch process, each piece 
of equipment has some amount of idle time. The significantly higher fixed costs for the batch 















Section 20: Other Important Considerations 
Section 20.1 Location Determination 
            Some pharmaceutical manufacturing hotspots in the world are the US, China, Kenya, 
UAE, and Switzerland. Initially, an international location was considered for the location of the 
manufacturing facilities as 80% of active pharmaceutical ingredient (API) manufacturers are 
located outside the US [25]. Most pharmaceuticals used in the US are either made in China or 
India or use ingredients from those countries [25].  
China and India were initially considered as locations for the manufacturing facilities. 
Some benefits of choosing India or China as the location include lower transportation, labor, 
infrastructure, and equipment costs [9]. Indian and Chinese firms have less environmental 
regulations around buying, handling, and disposing of toxic chemicals. This leads to lower direct 
costs for these businesses [9]. Additionally, there are lower barriers to market entry in India and 
China. However, factors such as regulatory approval, language barriers, and importation costs 
represent the cons of building the manufacturing plants in India or China. 
            To simplify the economic analysis and avoid the hassle of international regulations, it 
was decided that the manufacturing plants would be located in the US. The reshoring initiative 
supports this decision. The reshoring initiative works to bring manufacturing back to the US 
from overseas [63]. This initiative helps with strengthening the U.S. economy as it balances the 
trade and budget deficits, reduces unemployment by creating good and well-paying 
manufacturing jobs, and fosters a skilled workforce. The benefits of reshoring to the 
manufacturing companies include reducing the total cost of their products, improving their 
balance sheets, and increasing effectiveness for product innovations. These benefits are achieved 
by using the different resources provided by the Reshoring Initiative, such as the total cost of 
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ownership estimator, case studies, reshoring library, webinars, news items and presentations 
[63]. 
            Reshoring also helps companies avoid problems due to international currency 
fluctuations, tariffs, and logistics. With reshoring, manufacturing plants can better protect trade 
secrets and patents. There is an abundant supply of natural gas in the US that can keep operating 
costs reasonable. Local and state governments give tax incentives and enterprise zones to 
incentivize companies to build manufacturing plants in their state or locality. Additionally, labor 
costs in China are increasing, while US labor costs have remained flat over a decade [4]. Costs of 
managing remote suppliers and production facilities can be high and managerial requirements of 
a global business are significant. The cost of an elongated supply chain is high [4]. Hidden costs 
can arise in typical low-cost manufacturing countries due to corruption. Some examples of 
corruption are illegal payments, deliberately omitting quality processes, and theft of intellectual 
property [4]. 
           Within the US, we decided to build the plant in New Jersey. In New Jersey, there is a 
2.1% tax rate for a new facility and a 5% tax rate for a new facility, which is lower as compared 
to that in other states. There are 230 establishments in pharmaceutical preparation manufacturing 
facilities, and the number of these facilities grew by 26.8% from 2014 to 2019 [40]. A majority 
of life sciences industry related establishments can be found along major highways in New 
Jersey within a close proximity to New York, New York [40]. New Jersey is close to consumer 
markets both within and outside the US. It is a global transportation hub as it is home to the Port 
of New York and New Jersey, has good rail connectivity, and many international destinations 
can be reached by daily nonstop flights at airports [48]. A business located in central New Jersey 
can serve more than 38 million consumers within a two-hour drive and can reach 33% of the 
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United States population within a day’s drive from any location in New Jersey [48]. New Jersey 
also has a highly educated workforce. 40% of New Jersey’s workforce graduates from college 
with a bachelor’s degree or higher, while the national average is 32% [48]. 
 
Section 20.2 Environmental and Social Implications  
 During both manufacturing processes, powders are involved, and dust can be produced 
during different operations in the processes. Dust produced during manufacturing is a health 
hazard as an excess of the fine particulate matter in air can lead to a dust explosion. Therefore, 
all dust in both manufacturing facilities will have to be contained. The pieces of equipment that 
were selected for both processes ensure that all the dust is contained. Additionally, the 
appropriate personal protective equipment (PPE) will be provided to the operators to protect 
them while they are working in the facilities.  
The batch and continuous processes generate exhaust air and evaporated water during the 
granulation and drying and also during tablet coating. These are not harmful to the environment. 
Additionally, both processes use a substantial amount of utilities, including processing water, 
steam, and electricity, and this contributes to high energy and water usage demands. The 
continuous process has slightly higher electricity demand than the batch processes, while the 
batch process has a higher steam and water demand than the continuous process, as shown in 
Section 19.2.2.  
Continuous processes can be more efficiently scaled up. The throughput can be increased 
without having to change the equipment being used. Additionally, experiments can be set up 
more quickly for a continuous process compared to those for a batch process [34]. This is 
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important in case of a public health emergency, as a continuous process can be used to rapidly 
scale up production to meet increased demand for a drug. 
 
Section 20.3 Shipping 
 To make sure that there is enough inventory to keep the facilities running in case of 
emergencies, shipments of 13.5 tonnes (or 28 super sacks) of excipients will be received twice a 
month. As the API is transferred within the company in the US, 13.5 tonnes of the API will be 
delivered via truck twice a month. The excipients, which will be shipped from outside the US, 
will arrive in super sacks loaded in a shipping container. A shipping container is 40 ft long, 8 ft 
wide, and 8.5 ft tall, and each super sack is 35 inches long, 35 inches wide, and 48 inches tall. A 
truckload is assumed to hold the same number of super sacks as a shipping container. For a bulk 
density of 0.5 kg/L, 28 super sacks of API and excipients would be needed in each shipment in a 
month to meet the tablet production targets. The bulk density is used to find the volume occupied 
by 13.5 tonnes of API, which is subsequently used to calculate the number of super sacks needed 
to hold that volume of API. Similar calculations are done for the excipients. Therefore, a 
truckload of API and a shipping container of excipients would contain 28 super sacks each. 
Pallets with an area of 36 inches square are used for support under each super sack. Thus, 28 
pallets each are present for the super sacks in the truckloads of API and in the shipments of 
excipients to be received twice a month. Based on a recommendation from Professor Vrana, the 
average inventory for each facility would include two shipments of API and excipients—one 
shipment in the warehouse, and one en route to the facility. 
 The product is sent for packaging via trucks once a month. After tablet coating, the 
tablets will be stored in the Rhino BV-60 bins discussed in Section 17.1. These bins have a 
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volume of 90 ft3. Therefore, the number of bins needed to store the tablets produced in a month 
was calculated to be 42. The average product inventory will be 1.5 truckloads, with one 
truckload having the same dimensions as the shipping container discussed earlier. One truckload 
will be able to hold 30 bins. Thus, 1.5 truckloads are needed every month to send the tablets to 
the packaging facility.    
Table 20.3.1 Information for shipping raw materials and products 
For shipping of raw materials: 
Volume of a shipping container 2720 ft3 
Volume of a super sack 34 ft3 
Mass of API in each shipment in a month 13.5 tonnes 
Mass of excipients in each shipment in a month 13.5 tonnes 
Number of super sacks containing API in each shipment in a month 28 super sacks 
Number of super sacks containing API in each shipment in a month 28 super sacks 
Total number of super sacks in one shipment 56 super sacks 
Total number of pallets in one shipment 56 pallets 
For shipping of product: 
Mass of tablets made in one month 54.2 tonnes 
Volume of one bin 90 ft3 
Number of bins needed to ship the tablets to a packaging facility 42 bins 
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Section 20.4 Cleaning 
 Cleaning the equipment for both processes is necessary to maintain product quality and 
output. Time would be taken away from manufacturing for cleaning the equipment in the 
continuous process. A reasonable run length for the continuous process before it is shut down for 
cleaning was determined by a sensitivity analysis. This run length will be used by the process 
R&D team to further optimize the process and select a suitable cleaning reagent. The process run 
length had to be long enough to ensure that the plant would produce a sufficient number of 
tablets to be profitable while also maintaining the quality of those tablets. Increasing the process 
run length increases profits but carries the risk of reducing product output and quality due to 
infrequent cleaning. Therefore, a process run length that maintained both profits and quality was 
estimated using a sensitivity analysis. 
 Based on a recommendation from our project author, it was assumed that one round of 
cleaning would require 16 hours—4 hours for shutting down the process and disassembling the 
equipment, 8 hours for cleaning the disassembled equipment, and 4 hours for reassembling the 
equipment and starting up the process. For different process run lengths, the number of rounds of 
cleaning and subsequently the total revenue lost because of the time spent in cleaning instead of 
producing tablets was calculated. The revenue from each tablet was $0.01. It was found that 
changing the process length from one week to four weeks led to a substantial percentage increase 
in profits. However, increasing the process length above four weeks did not significantly 
increase profits. Therefore, a reasonable target run length for both processes to be used by the 
process R&D team was determined to be four weeks. Detailed calculations for the sensitivity 
analysis are in Section 25.5. 
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 It should be noted that increasing the process run length could also increase costs of 
cleaning as greater buildup of residue in the equipment could warrant the use of larger amounts 
of the cleaning reagent. However, this is to be calculated and optimized by the process R&D 
team and is out of scope for this report.  
 For the batch process, the equipment will be cleaned after every campaign of 8 batches. 
The costs of using clean-in-place and steam-in-place operations for cleaning all the equipment 
except the tablet press were calculated. The tablet press cannot be cleaned by steam-in-place and 
clean-in-place operations as it runs semi-continuously. The calculated costs were low as 
compared to other process costs, such as the costs of equipment and utilities, and so they were 
neglected in the profitability analysis. Calculations for the cost of cleaning for the batch process 
are included in the Section 25.5. 
Table 20.4.1 Table showing the impact on profits when process run length is increased 
Change in process run length Percentage increase in profits 
From 1 week to 4 weeks 8% 
From 4 weeks to 8 weeks 1.2% 














Section 21: Profitability Analysis—Business Case 
Section 21.1 Cash Flow Model 
Beginning in 2022, the plant will be designed for 1 year, constructed for 1 year and 
produce tablets for 21 years. The plant is assumed to operate at 90% of the total capacity for all 
years. For this part of the analysis, a cost of $0.01/tablet is used, and this will be evaluated in 
Section 21.3. As described in Section 18, the total capital investment is $31.6 million and $24.2 
million for the batch and continuous process respectively. A tax rate of 23% was used as the 
plants will be built in the US. The full cash flow model and for both processes and equations 
used to calculate cash flow can be found in Section 25.8. Table 21.1.1 and Table 21.1.2 show a 
summary of cash flow for the batch and continuous process respectively. The cumulative net 
present value at an interest rate of 15% shows that the manufacturing plant will have more cash 
leaving than entering. This can be seen in Table 21.1.1 and Table 21.1.2 as the cumulative net 
present is negative up until 2044 for both processes. Overall, the net present value (NPV) in 2044 
totals to ($17,605,300) and ($6,725,800) for the batch and continuous processes respectively. As 
the cumulative NPV in 2044 for the continuous process is less negative than that for the batch 




Table 21.1.1 Summary of Cash Flow for Batch Process ($0.01/tablet). For the unabridged cash 






($) Cash Flow ($) 
Cumulative Net 
Present Value at 
15% ($) 
0 2022 0% - - 
1 2023 0% (31,621,900) (27,497,300) 
2 2024 90% 2,325,200 (25,739,100) 
3 2025 90% 3,022,900 (23,751,500) 
4 2026 90% 2,278,700 (22,448,600) 
5 2027 90% 1,832,200 (21,537,700) 
6 2028 90% 1,832,200 (20,745,600) 
7 2029 90% 1,497,300 (20,182,700) 
8 2030 90% 1,162,400 (19,802,700) 
9 2031 90% 1,162,400 (19,472,300) 
10 2032 90% 1,162,400 (19,184,900) 
11 2033 90% 1,162,400 (18,935,100) 
12 2034 90% 1,162,400 (18,717,800) 
13 2035 90% 1,162,400 (18,528,900) 
14 2036 90% 1,162,400 (18,364,600) 
15 2037 90% 1,162,400 (18,221,800) 
16 2038 90% 1,162,400 (18,097,500) 
17 2039 90% 1,162,400 (17,989,500) 
18 2040 90% 1,162,400 (17,895,600) 
19 2041 90% 1,162,400 (17,813,900) 
20 2042 90% 1,162,400 (17,742,900) 
21 2043 90% 1,162,400 (17,681,100) 



















Table 21.1.2 Summary of Cash Flow for Continuous Process ($0.01/tablet). For the unabridged 
cash flow table, see Table 25.8.2. 
 
Year number Year 
Percentage of 
Design Capacity ($) Cash Flow ($) 
Cumulative Net 
Present Value at 
15% ($) 
0 2022 0% - - 
1 2023 0% (24,268,400) (21,103,000) 
2 2024 90% 3,020,500 (18,819,100) 
3 2025 90% 3,555,800 (16,481,100) 
4 2026 90% 2,984,800 (14,774,500) 
5 2027 90% 2,642,200 (13,460,800) 
6 2028 90% 2,642,200 (12,318,500) 
7 2029 90% 2,385,300 (11,421,800) 
8 2030 90% 2,128,400 (10,726,000) 
9 2031 90% 2,128,400 (10,121,000) 
10 2032 90% 2,128,400 (9,594,900) 
11 2033 90% 2,128,400 (9,137,500) 
12 2034 90% 2,128,400 (8,739,600) 
13 2035 90% 2,128,400 (8,393,700) 
14 2036 90% 2,128,400 (8,092,900) 
15 2037 90% 2,128,400 (7,831,400) 
16 2038 90% 2,128,400 (7,603,900) 
17 2039 90% 2,128,400 (7,406,100) 
18 2040 90% 2,128,400 (7,234,200) 
19 2041 90% 2,128,400 (7,084,600) 
20 2042 90% 2,128,400 (6,954,600) 
21 2043 90% 2,128,400 (6,841,500) 
22 2044 90% 2,503,100 (6,725,800) 
 
Section 21.2 Profitability Measures 
As mentioned in Section 21.1, this economic analysis is only conducted for 21 years of 
production with a tablet selling price of $0.01/tablet. Additionally, using guidelines from Seider 
et al [51], an inflation rate of 2% is used throughout the analysis. Table 21.2.1 summarizes the 
profitability measures achieved by this economic analysis for both processes. The IRR was found 
by setting the NPV to zero for both processes. The equations used to calculate ROI can be found 
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in Section 25.9. The batch process was not profitable for a selling price of $0.01/tablets, with an 
ROI of -2.39% and IRR of -0.30%. The continuous process was more profitable for the same 
selling price, with an ROI of 2.71% and IRR of 8.44%. 
Table 21.2.1 Profitability Measures for Batch and Continuous ($0.01/tablets) 
 Batch Continuous 
Internal Rate of Return (IRR) -0.30% 8.44% 






ROI Analysis (Third Production 
Year) 
 
























ROI  -2.39% 2.71% 
 
Section 21.3 Sensitivity Analysis—Selling Price of Tablets 
Section 21.2 shows that at $0.01/tablet, both the manufacturing plants would not be very 
profitable, especially the batch process. Table 21.3.1 and Table 21.3.2 show that increasing the 
selling price of the tablets from $0.01/tablet to $0.02/tablet would make both processes more 
profitable. Also, for a selling price of $0.02/tablet, the batch process would no longer have a 
negative IRR and ROI. For the batch process, Table 21.3.1 shows that increasing selling price 
from $0.01/tablet to $0.02/tablet will increases the IRR from -0.30% to 25.80% and increase the 
ROI from -2.39% and 17.29%. For the continuous process, Table 21.3.2 shows that increasing 
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selling price from $0.01/tablet to $0.02/tablet will increases the IRR from 8.44% to 37.10% and 
increase the ROI from 2.71% and 27.97% for the continuous process. It can be concluded that 






















Table 21.3.1 Profitability Measures for Batch Process at Different Selling Prices  
 $0.01/tablet $0.02/tablet $0.03/tablet 
Internal Rate of Return (IRR) -0.30% 25.80% 46.39% 






ROI Analysis (Third Production Year)  



















































Table 21.3.2 Profitability Measures for Continuous Process at Different Selling Prices  
 $0.01/tablet $0.02/tablet $0.03/tablet 
Internal Rate of Return (IRR) 8.44% 37.10% 62.95% 






ROI Analysis (Third Production Year)  

















































Section 22: Conclusions and Recommendations 
 The goal of this project was to design a process to formulate a small molecule drug 
product with an anticipates sales of 1 billion tablets per year, and a goal cost of conversion of 
$0.01 per tablet through the evaluation of both a batch and a continuous process. The goal 
conversion of $0.01 per tablet is ambitious in the pharmaceutical industry, as is reflected by the 
results presented in this report. Through rigorous profitability analysis, it was found that at a cost 
of conversion of $0.01 per tablet, the batch process is not profitable, and the continuous process 
is marginally profitable. However, when the cost of conversion is increased to $0.02 per tablet, 
the profitability of both processes increases significantly, as shown in Table 22.1.  




 IRR NPV ROI IRR NPV ROI 
Batch -0.30% ($17,605,300) -2.39% 25.80% $16,548,000 17.29% 
Continuous 8.44% ($6,725,800) 2.71% 37.08% $26,931,800 27.97% 
 
 Based on these results, we recommend that pharmaceutical companies looking to mass 
produce a small molecule drug product pursue a continuous manufacturing method. The 
profitability analysis shows that while the continuous process may require higher utility costs, 
the capital costs are significantly lower, and less operators are needed to run the continuous 
facility, resulting in significantly greater profits as compared to traditional batch manufacturing.  
We also recommend a cost of conversion greater than $0.01 per tablet to earn substantial profit. 
Annual production of 1 billion tablets sold at $0.02 per tablet for a plant life of 21 years results in 
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an IRR and ROI as high as 37% and 28% respectively for the continuous process. Regardless of 
the cost of conversion, the company should implement the continuous manufacturing process to 
maximize profits.  
 Continuous manufacturing of small molecule pharmaceuticals is a new process that 
pharmaceutical companies have been slow to adapt, yet this report reflects the potential 
economic implications of the adoption of this type of manufacturing in new pharmaceutical 
production plants. Lower production costs will allow for a higher volume of production, lower 
product prices, and therefore increased public accessibility to drugs necessary to maintain high 
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Section 25: Appendix 
Section 25.1. Problem Statement 
Formulation of a High-Volume Small Molecule Drug Product 
 
Background 
Most small molecule Active Pharmaceutical Ingredients, API’s, are formulated into 
tablets in large batches on the order of millions of tablets or more.  The Critical Quality 
Attributes, CQA’s, are typically the assay of the API and dissolution measured in vitro as well 
tablet properties such as weight, thickness, hardness and appearance. A typical process to 
formulate the API would include some type of granulation of the API, blending of the granules 
with other solids, compression of the blend into tablets, and application of a coating to give the 
tablets the required appearance.  Recently continuous manufacturing of tablets has become more 
and more popular in the pharmaceutical industry due to advantages inherent to continuous 
manufacturing for high-volume products.  In both cases, batch and continuous manufacturing, 
modern facilities are typically built with a good deal of automation so that paper batch records 
are not required, and data is automatically gathered electronically.   
 
Project Statement 
You will be working on a project where you must design a process to formulate 
Clairatenol a blockbuster drug product with anticipated sales of 1 billion tablets per year, and 
design the production facility in which it will be manufactured.  You should evaluate both batch 
and continuous manufacturing and target a cost for conversion into tablets of 1 cent per tablet.  
The granulation step can be run in a high shear granulator in the case of batch production or in a 
twin-screw granulator in the case of continuous manufacturing.  The blending step can be run in 
a bin blender in the case of batch production and in a continuous blender in the case of 
continuous manufacturing.  In both cases the tablet press will be the same or similar.  The tablet 
is coated but a reliable continuous tablet coater may not be commercially available so unless one 
is recommended by the project team, the coating can be done in a “semi-batch” mode in the case 
of continuous production.  Semi-batch coaters for continuous manufacturing of tablets are 
typically smaller coaters where the cycle time of the coating batch is matched with the 
throughput of the continuous line such that it is always in use (including charging and 
discharging).  
Once you have designed the process, you will need to design the manufacturing facility, 
keeping in mind the differences in the size of the equipment and how that will impact the 
footprint of the facility.  As you design the facility, you should do your best to keep capital costs 
of the equipment and operating costs of the facility to a minimum.  You can build the plant 
anywhere in the world, but you should consider things like cost of labor and availability of 
dependable supplies of utilities such as electricity and water when you choose the location.  The 
facility should be designed so that the operators are safe from hazards like inhaling dust from the 
powders, no waste is released to the environment, and any risks of dust explosions are accounted 
for in the design.  The final design should compare a batch and a continuous process, ultimately 
making a recommendation as to which is a wiser investment. 
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25.2.1 SuperPro for the Batch Process  
 
 


































   
Figure 25.2.2. SuperPro report of overall process data for the batch process.  
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Figure 25.2.3. First part of SuperPro stream report for the batch process. This report was 
used to double check material balance calculations. Excipients were modeled as 
“carbohydrates” in the SuperPro software.  
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Figure 25.2.5. Continuation of SuperPro stream summary for the batch process.  
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Figure 25.2.8. First part of SuperPro stream report for the continuous process. This report was 
used to double check material balance calculations. Excipients were modeled as “carbohydrates” 





Figure 25.2.9. Continuation of SuperPro stream summary for the continuous process.  
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Section 25.3 Energy Balance Calculations 
25.3.1 Energy Balance Calculations for Granulation 
The mechanical work required for both fluid bed and twin-screw granulation is assumed to be 
equal to the motor power of the heat exchangers, pumps, blowers, and vessels. Thus, work is 
omitted from energy balance calculations and the resulting heat balances are reported below. 




𝑇𝑓 − ∅𝑖 
𝑇𝑖) ∗ ?̇?𝑎𝑖𝑟 ∗ 𝑡  
1000




𝑄𝑎𝑖𝑟 =  𝑚𝑔𝑟𝑎𝑛𝐶𝑝,𝑔𝑟𝑎𝑛𝛥𝑇𝑔𝑟𝑎𝑛 +  𝑚𝑤𝑎𝑡𝑒𝑟𝐶𝑝,𝑤𝑎𝑡𝑒𝑟𝛥𝑇𝑤𝑎𝑡𝑒𝑟 + 𝑚𝑤𝑎𝑡𝑒𝑟,𝑣𝑎𝑝𝛥𝐻𝑣𝑎𝑝,𝑤𝑎𝑡𝑒𝑟   
 (Eqn. 25.3.2) 
 
 𝑄𝑎𝑖𝑟 =  ?̇?𝑎𝑖𝑟𝐶𝑝,𝑎𝑖𝑟𝛥𝑇𝑎𝑖𝑟 =   𝜌?̇̇?𝑎𝑖𝑟𝐶𝑝,𝑎𝑖𝑟𝛥𝑇𝑎𝑖𝑟  
(Eqn. 25.3.3) 
 
 𝑄𝑠𝑡𝑒𝑎𝑚 =  𝑄𝑎𝑖𝑟   
(Eqn. 25.3.4) 
 




Steam requirement calculations were conducted using equations 25.3.3 to 25.3.5 above. 
The amount of water evaporated during granulation is calculated using equation 25.3.1, where 
∅𝑠𝑎𝑡 
𝑇𝑓
is the absolute humidity the saturated exhaust air, ∅𝑖 
𝑇𝑖 is the inlet absolute humidity (both 
are measured in g water/kg air), and t is time. An important assumption made for these 
calculations is that the pressure increase from the blower was small enough such that air 
properties are taken to be at ambient conditions. Equations 25.3.1 to 25.3.5 are not relevant for 
continuous twin-screw granulation as there is no hot air input to that process. 
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Centrifugal blowers are required to increase the velocity of air upstream of each of the 
heat exchangers. Blower motor power is a function of volumetric flow rate and pressure increase 
across the blower. The following correlations from Seider et al., were used to determine blower 
motor power. 
 












− 1]      
(Eqn. 25.3.6) 
𝑃𝐶 =  
𝑃𝐵
𝜂𝑀
    
(Eqn. 25.3.7) 
Where 𝑃𝐵 is the brake horsepower, k is a constant specific heat ratio, Q1 is the volumetric 
flow rate, P1 is outlet pressure, P0 is inlet pressure, ηB is blower efficiency, ηM is blower motor 
efficiency, and PC is power consumption by the blower motor.  
 
25.3.2 Energy Balances for Fluid Bed Drying 
The mechanical work required for both continuous and batch fluid bed drying is assumed to be 
equal to the motor power of the heat exchangers, pumps, blowers, and vessels. Thus, work is 
omitted from energy balance calculations and the resulting heat balances are reported below. 
Equations 25.3.3 to 25.3.5 hold for fluid bed drying. While fluid bed granulation operates at 
ambient, saturated conditions, fluid bed drying operates at 40ºC. For the batch process, there is 
idle time between each equipment use and the energy required to reheat the vessel for each batch 
must be considered. Therefore, for batch fluid bed drying, equation 25.3.2 is modified to 
equation 25.3.8 below. 
 
𝑄𝑎𝑖𝑟 =  𝑚𝑔𝑟𝑎𝑛𝐶𝑝,𝑔𝑟𝑎𝑛𝛥𝑇𝑔𝑟𝑎𝑛 +  𝑚𝑤𝑎𝑡𝑒𝑟𝐶𝑝,𝑤𝑎𝑡𝑒𝑟𝛥𝑇𝑤𝑎𝑡𝑒𝑟 +  𝑚𝑣𝑒𝑠𝑠𝑒𝑙𝐶𝑝,𝑣𝑒𝑠𝑠𝑒𝑙𝛥𝑇𝑣𝑒𝑠𝑠𝑒𝑙




Exhaust air humidity is calculated using equation 25.3.9. 
 
∅𝑓
𝑇2 =  
(𝑚𝑤𝑎𝑡𝑒𝑟,𝑡𝑜𝑡 − 𝑚𝑤𝑎𝑡𝑒𝑟,𝑔𝑟𝑎𝑛) 





The power required by the blowers is calculated using equations 25.3.6 and 25.3.7. 
 
25.3.3 Energy balance calculations for milling in batch and continuous processes 
Main energy balance equation: ∆𝐸 = 𝑄 − 𝑊 
∆𝐻 + ∆𝐾𝐸 + ∆𝑃𝐸 = 𝑄 − 𝑊 
 (Eqn. 25.3.10) 
Neglecting ∆PE because the distance between the mill inlet and outlet is small (~0.4 m for 
Quadro FlexSift S20), 
∆𝐻 + ∆𝐾𝐸 = 𝑄 − 𝑊 
(Eqn. 25.3.11) 
For calculating ∆H,  
∆𝐻 = 𝑚 ∙ 𝐶𝑝 ∙ ∆𝑇 
(Eqn. 25.3.12) 
Both the API and excipients are assumed to have the same properties as water (Cp = 4.18 kJ/kg 
K). All the data below was obtained from Quadro FlexSift S20 brochures and from speaking 









Table 25.3.1 Summary of mill energy balance calculations for the batch process 
Parameters Values 
Temperature of inlet stream to mill 25°C 
Temperature of outlet stream from mill 28°C 
Duration of milling 3 hours 
Inlet Stream Mass of API 1000 kg (333 kg/hr) 
Mass of excipients 560 kg (187 kg/hr) 
Outlet Stream Mass of API 1000 kg (333 kg/hr) 
Mass of excipients 560 kg (187 kg/hr) 
Mill rotational speed 700 RPM 
Drive motor 3.73 kW 
Friction factor 0.014 
Shaft work (W) -3.7 kW 
∆H 1.8 kW 
∆KE 0.004 kW 
Heat released (Q) -1.9 kW 
Heat capacity of material going through mill 6520.8 kJ/K 
Temperature rise in the material if all the heat released is 







For the mill used in the continuous process, the value for the drive motor is lower due to lower 
throughput. A lower amount of energy is needed for milling the lower throughput to the mill for 
the continuous process.  
Table 25.3.2 Summary of mill energy balance calculations for the continuous process 
Parameters Values 
Temperature of inlet stream to mill 25°C 
Temperature of outlet stream from mill 28°C 
Inlet Stream Mass of API 41 kg/hr 
Mass of excipients 23 kg/hr 
Outlet Stream Mass of API 41 kg/hr 
Mass of excipients 23 kg/hr 
Mill rotational speed 700 RPM 
Drive motor 0.55 kW 
Friction factor 0.014 [49] 
Shaft work (W) -0.54 kW 
∆H 0.22 kW 
∆KE 0.0005 kW 
Heat released (Q) -0.32 kW 
Heat capacity of material going through mill (for the material 
going through the mill in one hour) 
269 kJ/K 
Temperature rise in the material if all the heat released is 
absorbed by the material 
4°C 
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25.3.4 Energy balance calculations for blending in batch and continuous processes 
 
Main energy balance equation: ∆𝐸 = 𝑄 − 𝑊 
 
∆𝐻 + ∆𝐾𝐸 + ∆𝑃𝐸 = 𝑄 − 𝑊 
(Eqn. 25.3.13) 
∆PE = 0 for the bin blender because blender rotation causes the powder to rise and fall back 
down repeatedly. 
 
∆PE = 0 for the continuous blender because the continuous process is a horizontal manufacturing 
line (solids flow is handled in a horizontal manner) and the continuous blender (which is 
cylindrical in shape) is positioned such that its axis is parallel to the ground. 
 
∆𝐻 + ∆𝐾𝐸 = 𝑄 − 𝑊 
(Eqn. 25.3.14) 
For calculating ∆H,  
 
∆𝐻 = 𝑚 ∙ 𝐶𝑝 ∙ ∆𝑇 
(Eqn. 25.3.15) 
 
Both the API and excipients are assumed to have the same properties as water (Cp = 4.18 kJ/kg 
K). All the data below was obtained from LB Bohle PM-6000 brochures and from speaking with 












Table 25.3.3 Summary of blending energy balance calculations for the batch process 
Parameters Values for pre-blender Values for blender 
Temperature of inlet stream 1 to blender 22°C 28°C 
Temperature of inlet stream 2 to blender 22°C 25°C 
Temperature of outlet stream from blender 25°C 30°C 
Duration of blending 40 minutes 40 minutes 
Inlet Stream 1 Mass of API 1000 kg 1000 kg 
Mass of excipients 0 560 kg 
Inlet Stream 2 Mass of API 0 0 
Mass of excipients 520 kg 360 kg 
Outlet Stream Mass of API 1000 kg 1000 kg 
Mass of excipients 520 kg 920 kg 
Blender rotational speed 5 RPM 5 RPM 
Drive motor 25.5 kW 25.5 kW 
Shaft work (W) -61,200 kJ -61,200 kJ 
∆H 19,060 kJ 20,566 kJ 
∆KE 0.23 kJ 0.3 kJ 
Heat released (Q) -42,140 kJ -40,634 kJ 
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Heat capacity of material going through 
blender 
6354 kJ/K 8025.6 kJ/K 
Temperature rise in the material if all the heat 
released is absorbed by the material 
6.6°C 5°C 
The blender rotational speed is higher for the continuous blender because of its lower 
throughput. A higher rotational speed is needed to homogenize the mixture when the amount of 
material present in the blender at any given moment is relatively small [8]. 
All the data below was obtained from Gericke GCM-450 brochures and from speaking 




















Table 25.3.4 Summary of blending energy balance calculations for the continuous process 
Parameters Values for pre-blender Values for blender 
Temperature of inlet stream 1 to blender 22°C 28°C 
Temperature of inlet stream 2 to blender 22°C 25°C 
Temperature of outlet stream from blender 25°C 30°C 
Inlet Stream 1 Mass of API 41 kg/hr 41 kg/hr 
Mass of excipients 0 23 kg/hr 
Inlet Stream 2 Mass of API 0 0 
Mass of excipients 21 kg/hr 15 kg/hr 
Outlet Stream Mass of API 41 kg/hr 41 kg/hr 
Mass of excipients 21 kg/hr 38 kg/hr 
Blender rotational speed 25 RPM 25 RPM 
Drive motor 0.37 kW 0.37 kW 
Shaft work (W) -0.37 kW -0.37 kW 
∆H 0.22 kW 0.24 kW 
∆KE 1.1E-7 kW 1.5E-7 kW 
Heat released (Q) -0.15 kW -0.13 kW 
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Heat capacity of material going through 
blender (for the material going through the 
blender in one hour) 
261 kJ/K 331 kJ/K 
Temperature rise in the material if all the 





25.3.5 Energy Balance for Rotary Tablet Press. 
The work done by and the energy of the rotary tablet press can be found using the following 
equations. 
∆𝐸 = 𝑊 − 𝑄 
(Eqn. 25.3.16) 
𝑄 = 𝑚 × 𝐶𝑃 × ∆𝑇 
(Eqn. 25.3.17) 
𝑊𝐶𝑜𝑚𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 𝑓𝑜𝑟𝑐𝑒 = 𝐹𝑐𝑜𝑚𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 × 𝑣𝑡𝑢𝑟𝑟𝑒𝑡 
(Eqn. 25.3.18) 
All the information used for these calculations were found on GEA’s website for the MODUL™ 
P Tablet Press (GEA). One exception is the turret speed, which was provided by speaking to a 
vendor. Tables 25.3.5 and Table 25.3.6 represent the summary of the energy balance calculations 
for the batch and continuous processes respectively. The main difference between the two 
processes is that tablet heat gain because the feed rate for the tablet press is more for the batch 










Table 25.3.5 Summary of Tablet Press for Batch Process Energy Balance Calculations 
Parameters Values 
Inlet Temperature (°C) 30 
Outlet Temperature(°C) 32 
Temperature change (°C) 2 
Heat Capacity (J/g°C) 4200 
Turret speed (rpm) 50 
Turret speed (m/s) 5.24 
Main compression force (kN) 80 
Tablet heat gain (kW) 213 
Work done by compression force (kW) 419 













Table 25.3.6 Summary of Tablet Press for Continuous Process Energy Balance Calculations 
Parameters Values 
Inlet Temperature (°C) 30 
Outlet Temperature(°C) 32 
Temperature change (°C) 2 
Heat Capacity (J/g°C) 4200 
Turret speed (rpm) 50 
Turret speed (m/s) 5.24 
Main compression force (kN) 80 
Tablet heat gain (kW) 184 
Work done by compression force (kW) 419 
Energy of  tablet press (kW) 235 
 
25.3.6 Energy Balance for Batch and Continuous Tablet Coater 
 
A thermodynamic model of the tablet coating system will allow us to determine the heat 
loss of the system by taking into account the enthalpy change of the processing air, and the 
enthalpy change of the coating. For this calculation, we are assuming that 90% of the coating 
solution is water and all that water is evaporated during drying. The following equations are used 
to develop the thermodynamic model for the batch and continuous systems.  
∆𝐻 = ∆𝐻𝑎𝑖𝑟+∆𝐻𝑐𝑜𝑎𝑡+∆𝐻𝑡𝑎𝑏𝑙𝑒𝑡 + ∆𝐻𝑙𝑜𝑠𝑠=0 
(Eqn. 25.3.19) 




∆𝐻𝑐𝑜𝑎𝑡 =  𝑥𝑤𝑚𝑐𝑜𝑎𝑡𝐶𝑝,𝑤(𝑇𝑎𝑖𝑟,𝑜𝑢𝑡 − 𝑇𝑐𝑜𝑎𝑡)+ 𝑥𝑤𝑚𝑐𝑜𝑎𝑡∆𝐻𝑣,𝑤  +
                         𝑥𝑜𝑟𝑔𝑚𝑐𝑜𝑎𝑡𝐶𝑝,𝑜𝑟𝑔(𝑇𝑎𝑖𝑟,𝑜𝑢𝑡 − 𝑇𝑐𝑜𝑎𝑡)+ 𝑚𝑐𝑜𝑎𝑡∆𝐻𝑣,𝑜𝑟𝑔   
                                ≈ 𝑚𝑐𝑜𝑎𝑡𝑖𝑛𝑔 𝐶𝑝,𝑤(𝑇𝑎𝑖𝑟,𝑜𝑢𝑡 − 𝑇𝑐𝑜𝑎𝑡)+ 𝑚𝑤∆𝐻𝑣,𝑤 
(Eqn. 25.3.21) 
The temperatures for the different streams going in and out of the batch tablet press were 
found using the Suteric Aqueous Enteric Coating System Technical Data Sheet, that can be found 
in Section 15.10.9. The temperatures for the different streams going in and out of the continuous 
tablet press were obtained using the Continuous Coater Publication sent by a Thomas 
Engineering representative and can be found in Section 25.10.11 [33]. Additionally, for these 
thermodynamic models, it was assumed that the tablet has a 15 mm diameter and 5 mm 













Table 25.3.7 Summary of Batch Tablet Coater Energy Balance Calculations 
Parameters  Values 
Inlet Load (kg) 1920 
Inlet coating (kg) 80 
Inlet coating solution (kg) 800 
Inlet Water (kg) 720 
Max Process air volume (m3/h) 17858 
Inlet tablet temperature (°C) 32 
Inlet coating solution temperature (°C) 25 
Inlet air Temperature (°C) 75 
Exhaust Temperature (°C) 45 
Product Temperature (°C) 45 
Tablet output (kg) 2000 
Tablet Diameter(mm) 15 
Tablet thickness(mm) 5 
Tablet volume(mm3) 884 
Tablet Surface area (mm2) 589 
Air heat capacity (J/kg°C) 700 
Air density (J/kg°C) 1.2 
Tablet heat capacity (water) 4200 
Coating heat capacity (J/g°C 4200 
Enthalpy of vaporization (kJ/kg) 2260 
Run time (hr) 6 
Coating heat (MJ) 8,347 
Atomizing air heat (MJ) -2700 









Table 25.3.8 Summary of Continuous Tablet Coater Energy Balance Calculations 
Parameters  Values 
Inlet Load (kg/hr) 78.8 
Inlet coating (kg/hr) 3.28 
Inlet coating solution (kg/hr) 32.83 
Inlet Water (kg/hr) 29.55 
Process air volume (m3/h) 6800 
Inlet tablet temperature (°C) 32 
Inlet coating solution temperature (°C) 25 
Inlet air Temperature  (°C) 57 
Exhaust Temperature (°C) 39 
Product Temperature (°C) 39 
Total tablet throughput rate (kg/hr) 82 
Tablet Diameter(mm) 15 
Tablet thickness(mm) 5 
Tablet volume(mm3) 884 
Tablet Surface area (mm2) 589 
Air heat capacity (J/kg°C) 700 
Air density (kg/m3) 1.2 
Tablet heat capacity (J/g°C) 4200 
Coating heat capacity (J/g°C) 4200 
Enthalpy of vaporization (kJ/kg) 2260 
Coating heat (kW) 72 
Atomizing air heat (kW) -29 
Heat loss of coater (kW) 44 
The calculations for the utilities for the pumps, heat exchangers and blowers can be found 
in Section 25.3.1 and Section 25.4. 
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Section 25.4 Equipment Design  
All the equations noted in this section were pulled from the Product and Process Design 
Principles textbook (Seider et al). Details regarding the design of the heat exchangers and 
blowers used in this system are detailed below.  
25.4.1 Heat Exchanger Design 
Section 15 details the logic behind the selected air volumetric flow rates, temperatures, 
and humidity. The air is heated to its determined temperature in a heat exchanger using 
condensed steam at 3.4 atm. Heat exchangers are used to heat the air that flows into the fluid bed 
granulator and dryer, the continuous fluid bed dryer, and both the batch and continuous coater. 
Countercurrent shell-and-tube heat exchangers were chosen. Once the heat duty of the heat 
exchanger was determined as shown in Section 25.3.1 (?̇?𝑠𝑡𝑒𝑎𝑚 = ?̇?𝑎𝑖𝑟 = ?̇?), heat exchanger 
design was performed using the following equations.  
 





      (25.4.1) 
 
𝐴 =  
?̇? 
𝑈 ∗ ∆𝑇𝑙𝑚 ∗  𝐹𝑇 
     (25.4.2) 
 
𝐹𝑇 was assumed to be 1 for each of the heat exchangers. Approximate values of the overall heat 
transfer coefficient U were found within Seider, et al, and used to calculate the area manually. 
Additionally, stream specifications were plugged into Aspen Plus to approximate the overall heat 
transfer coefficient and area necessary for each of the designs. Design specifications were set 
manipulate the flow rate of steam necessary to reach a specific outlet air temperature through 
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condensation of the steam. Values for the required steam flow were compared and found to be 
within 15% error, and the manually calculated flow rates were taken to be accurate. The area and 
overall heat transfer coefficient generated by Aspen were accepted as the correct design values.  
Electricity requirements to run each of the heat exchangers were taken from Aspen Plus once 
design was complete. Sample Aspen input and output files for the fluid bed dryer heat exchanger 
are included below. 
 Although costing correlations for shell-and-tube heat exchangers are available in Seider, 
et al., the costs of these pieces of equipment were included in vendor quotes for the granulator, 






























Section 25.5 Cleaning Costs 
The cost of cleaning for each process was taken to be negligible. The evidence for this 
assumption is presented below.  
Section 25.5.1 Cleaning Considerations for the Batch Process 
 It was reported from conversations with pharmaceutical batch manufacturing engineers 
(Dr. Marchut) that the batch equipment should be cleaned after every eight batches. Time did not 
have to be taken away from manufacturing to clean most of the equipment because of ample idle 
time. The tablet press, however, operates semi-continuously and must be cleaned during the 
annual downtime. Equipment is to be cleaned using Clean-in-Place (CIP) followed by Steam-in-
Place (SIP) operations included in the equipment. The amount of process water needed for each 
CIP and the amount of steam required for each SIP were taken from the SuperPro mode and are 
reported in Table 25.5.2 below. Table 25.5.1 shows the cost of the water, steam, SIP waste, and 
CIP waste for cost calculations. Costs of water and steam were sourced from Seider, et al., while 
costs of SIP and CIP waste were taken as given in SuperPro.  
Table 25.5.1 Cost of Cleaning Utilities and Waste Removal for the Batch Process 
Water $0.27/m3 
Steam $0.0132/kg 
CIP Waste $0.005/kg 






Table 25.5.2 Cost of Cleaning for the Batch Process 
Unit Operation Water per CIP (kg) Steam per SIP(kg) Waste Treatment Cost 
BD-1(C) 1495 100 $7.58 
GR-1(C)/DR-1(C) 1495 244 $7.72 
ML-1(C) 1495 6 $7.48 
BD-2(C) 1495 126 $7.60 
TP-1(C) Semi-continuous operation 
TC-1(C) 1495 357 $7.83 
Total 1495 832  
Cost ($) $2 $11 $38.22 
Total Cost per Clean   $50 
Total Annual Cost   $2,000 
 
The annual cost of $2,000 is low enough that it was taken as negligible in cost analysis 
calculations. 
 
25.5.2 Continuous Cleaning Considerations 
Unlike the batch process, time would have to be taken away from manufacturing to clean 
the equipment in the continuous process. Therefore, a reasonable process run length before the 
process is shut down for cleaning had to be estimated. For different values of process run length, 
the profit made from running the process was calculated. The percentage increase in profits when 
process run length is increased was also calculated. Each cleaning round takes 16 hours. The 
revenue from each tablet is $0.01. The revenue gained from running the process for a year with 
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no interruptions is $11.1 million. The total revenue lost because of cleaning is based on the 
number of tablets not made while the equipment was being cleaned. The percentage increase in 
profits is calculated for an increase in run length from the previous value to the current value. 
Table 25.5.3: Summary of calculations for determining process run length before cleaning 
Process run 
length before 



















1 week 52 35 1,053,000 10,007,000 — 
2 weeks 26 17 527,000 10,534,000 5% 
3 weeks 17 12 351,000 10,709,000 2% 
4 weeks 13 9 263,000 10,797,000 0.8% 
5 weeks 10 7 211,000 10,850,000 0.5% 
6 weeks 8 6 176,000 10,885,000 0.3% 





Section 25.6 Purchase Cost Calculations 
The following sections highlight the correlations used to calculate the purchase cost of 
equipment that can be found in the third column of Table 17.1.1 and Table 17.1.2. 
25.6.1 Granulator  
25.6.1.1 Batch Fluid Bed Granulation and Drying 
For batch granulation and drying, the correlations for a vertical pressure vessel and spray 
dryer respectively were used. This is a flawed assumption as the granulator is not a pressure 
vessel. For this calculation, the weight of the granulator is needed, and it was assumed the 
granulator would weigh 6500lbs. For the spray dryer, the size factor is evaporation rate, W 
(lb/hr) with a range of 30 to 3,000 lb/hr. Additionally, stainless steel is assumed as the material 
for the equipment, so the material factor FM was 2. The following equations were used to 
determine the purchase cost of the fluid bed granulator. 
𝐶𝑉,𝑔𝑟𝑎𝑛𝑢𝑙𝑎𝑡𝑜𝑟 = 𝑒𝑥𝑝(7.1390 + 0.18255 ln(𝑊) + 0.02297(ln(𝑊))
2 
(Eqn. 25.6.1) 
𝐶𝑃,𝑔𝑟𝑎𝑛𝑢𝑙𝑎𝑡𝑜𝑟 = 𝐹𝑀𝐶𝑉 
(Eqn. 25.6.2) 







Table 25.6.1 Summary of Purchase Cost Calculation for a Fluid Bed Granulator 
Parameters Values 
Granulation 
Weight (kg) 6500 
Weight (lb) 14,333 
Cv ($) 59,272 
FM 2 
CP, granulator($) 118,543 
Drying 
Mass of evaporated water per batch (kg/batch) 304 
Mass of evaporated water per batch (lb/batch) 669 
Run time (hr) 6 
Evaporation rate (lb/hr) 112 
CP, spray dryer($) 148,510 
CP, fluid bed granulator($) 267,053 
25.6.1.2 Continuous Twin Screw Granulation and Fluid Bed Drying 
For continuous granulation and drying, the correlations for a horizontal pressure vessel and 
screw extruder were used. This is a flawed assumption as the granulator is not a pressure vessel. 
For this calculation, the weight of the granulator is needed, and it was assumed the granulator 
would weigh 6500lbs. For the screw extruder, the size factor is feed rate, F (lb/hr) with a range 
of 8-800 lb/hr. Additionally, stainless steel is assumed as the material for the equipment, so the 
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material factor FM was 2. The following equations were used to determine the purchase cost of 
the twin screw granulator and fluid bed dryer. 
𝐶𝑉,𝑔𝑟𝑎𝑛𝑢𝑙𝑎𝑡𝑜𝑟 = 𝑒𝑥𝑝(5.6336 +  0.4599(𝑙𝑛(𝑊)) +  0.00582(ln(𝑊))
2 
(Eqn. 25.6.4) 
𝐶𝑃,𝑔𝑟𝑎𝑛𝑢𝑙𝑎𝑡𝑜𝑟 = 𝐹𝑀𝐶𝑉 
(Eqn. 25.6.5) 
𝐶𝑃,𝑠𝑝𝑟𝑎𝑦 𝑑𝑟𝑦𝑒𝑟 = exp (10.9186 +  0.02099(ln(𝐹))
2 
(Eqn. 25.6.6) 




Weight (kg) 6500 
Weight (lb) 14332.5 
Cv ($) 38872.02 
FM 2 
CP, granulator($) 77,744 
Drying 
Feed rate (kg/hr) 62.32 
Feed rate (lb/hr) 137.4156 






For the blender in both the batch and continuous process, the correlation for the tumbler 
(double cone) was used. However, a bin blender is used for the batch process and a continuous 
blender that is tubular in design is used for the continuous process. Therefore, this correlation 
does not correspond to the actual equipment being used in the processes. The size factor is 
volume V (ft3) with a range of 10-380 ft3. The following equation is used to determine the 




Table 25.6.3 Summary of Purchase Cost Calculation for a Blender 
Parameters Values 
Mass into blender (kg) 1920 
Bulk Density(kg/L) 0.5 
Volume (L) 3840 
Volume (ft3) 136 
CP ($) 30,318 
25.6.3 Mill 
For the mill in both the batch and continuous process, the correlation for the hammer mill 
was used. However, the mill used in both processes was gentler and helped in delumping particle 
agglomerates. Therefore, this correlation for the hammer mill, which is more aggressive than the 
mill used in the processes, does not correspond to the equipment used in the processes. The size 
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factor is feed rate W (tons/hr) with a range of 2-200 tons/hr. The following equation is used to 




Table 25.6.4 Summary of Purchase Cost Calculation for a Mill 
Parameters Values 
Feed rate (kg/hr) 64 
Feed rate (lb/hr) 140.8 
CP ($) 20,436 
 
25.6.4 Tablet Press 
For the tablet press in both the batch and continuous process, the correlation for the tablet 
press was used. The size factor is feed rate F (lb/hr) with a range of 800-8,000 lb/hr. However, 
the feed rates for both processes do not fall within this range. The following equation is used to 
determine the purchase cost of a tablet press. 






Table 25.6.5 Summary of Purchase Cost Calculation for a Tablet Press for batch Process 
Parameters Values 
Feed rate (kg/hr) 91 
Feed rate (lb/hr) 201 
CP($) 31,866 
Table 25.6.6 Summary of Purchase Cost Calculation for a Tablet Press for continuous Process 
Parameters Values 
Feed rate (kg/hr) 79 
Feed rate (lb/hr) 174 
CP($) 30,532 
 
25.6.5 Batch and Continuous Coater  
For the batch and continuous coater, the correlations for a vertical pressure vessel and 
spray dryer were used. This is a flawed assumption as the granulator is not a pressure vessel. For 
this calculation, the weight of the granulator is needed, and it was assumed the granulator would 
weigh 6500lbs. For the spray dryer, the size factor is evaporation rate W(lb/hr) with a range of 
30-3,000 lb/hr. Additionally, stainless steel is assumed as the material for the equipment, so the 
material factor FM was 2.00. The following equations were used to determine the purchase cost 
of the fluid bed granulator. 




𝐶𝑃,𝑔𝑟𝑎𝑛𝑢𝑙𝑎𝑡𝑜𝑟 = 𝐹𝑀𝐶𝑉 
(Eqn. 25.6.11) 




Table 25.6.7 Summary of Purchase Cost Calculation for a Batch Coater 
Parameters Values 
Coating 
Weight (kg) 6500 
Weight (lb) 14333 
Cv 59,272 
FM 2 
CP,coating ($) 118,543 
Drying 
Mass of water evaporated (kg) 720 
Run time (hr) 6 
Evaporation rate (kg/hr) 120 
Evaporation rate (lb/hr) 264.6 





Table 25.6.8 Summary of Purchase Cost Calculation for a Continuous Coater 
Parameters Values 
Coating 
Weight (kg) 6500 





Evaporation rate (kg/hr) 30 
Evaporation rate (lb/hr) 66.15 










25.6.6 Equipment cost of conveyors.  
The conveying distance between operations was taken to be 3 meters, and pneumatic 
conveyors are used to convey the material between unit operations, except for the transfer from 
the second blender to the tablet press, for which screw conveyors are used. Cost estimates for the 
purchase price of conveyers are found using the following equations. 








Section 25.7 Bare Module Costs Equation 
The following equation is used to calculate the bare module cost. 
𝐶𝐵𝑀 = 𝐹𝐵𝑀𝐶𝑝 
(Eqn. 25.7.1) 
Section 25.8 Cash Flow Model  
The following equations were used to calculate the cash flow. 
During construction years: 
𝐶𝐹 =  −𝑓𝐶𝑇𝐷𝐶 − 𝐶𝑊𝐶 
(Eqn. 25.8.1) 
 240 
During product manufacturing years: 
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Section 25.9 Profitability Measures  
The following equation was used to determine ROI: 





















Section 25.10 Equipment Brochures  
















































25.10.5 Quadro FlexSift S20 brochure 
It should be noted that although the power for the FlexSift S20 in the brochure is 5.6 kW, the 
value used in calculations for the batch process was 3.73 kW as the latter value was obtained 
from a call with a Quadro sales representative. The value used in calculations for the continuous 
process was 0.55 kW as the throughput for the continuous process is much lower than that for the 



















25.10.6 LB Bohle container blender (PM-6000) brochure 


























25.10.9 Suteric Aqueous Enteric coating system Technical Data Sheet 
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25.10.11 Continuous Coater Applications Publication 
This publication was obtained from a representative from Thomas Engineering. Here only part of 
the publication is included. This publication was used to obtain information for the temperatures 
of the streams going into and leaving TC-1(C) 
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